Prof Nick Fox

Photo

Personal Profile

Name: Nick Fox Email: n.fox@ucl.ac.uk
Title: Prof Tel: 020 3448 4773
Department: Neurodegenerative Diseases Fax: 020 3448 3104
Position: Professor of Neurology Address: Dementia Research Centre, Institute of Neurology, 8 - 11 Queen Square, London , WC1N 3BG
Research Domain: Biomedical Imaging (Frontier Disciplines), Neuroscience Web Page: Personal Web Page

Profile

Research Description

My research interests are focussed on the early detection, differential diagnosis and monitoring of progression in cognitive disorders and neurodegenerative dementias in particular. My particular interest within this broad grouping has been in the use of MRI to improve diagnosis and to measure progression in Alzheimer's disease and related disorders. I have been involved in the use of automated measures of cerebral atrophy derived from serial MRI to assess treatment efficacy and disease-modifying potential of novel therapies. I also have a particular interest in the familial dementias and the use of biomarkers and clinical and cognitive measures to assess the earliest manifestations of autosomal dominant dementias, both Alzheimer's disease and frontotemporal lobar degenerations.

Research Activities

Inflammatory conditions of the gastrointestinal tract

Investigating the molecular basis of frontotemporal dementia

Use of brain imaging to study dementia and Alzheimer's disease

Education Description

UCL Collaborators

Prof John Hardy; Prof Clare Futter; Prof Andrew Lees; Prof Sebastian Brandner; Dr Robin Ketteler; Prof Kailash Bhatia; Prof Mark Marsh; Dr Anna Barnes; Dr Kirsi Kinnunen; Dr Adrian Isaacs; Prof Martin Rossor; Prof Tamas Revesz; Prof Lucy Wedderburn; Dr David Thomas

External Collaborators

Prof Terje Johansen; Dr Anne Simonsen; Freja Consortium; Prof Christine Van Broeckhoven

Publications

    2014

    • Slattery CF, Beck JA, Harper L, Adamson G, Abdi Z, Uphill J, Campbell T, Druyeh R, Mahoney CJ, Rohrer JD, Kenny J, Lowe J, Leung KK, Barnes J, Clegg SL, Blair M, Nicholas JM, Guerreiro RJ, Rowe JB, Ponto C, Zerr I, Kretzschmar H, Gambetti P, Crutch SJ, Warren JD, Rossor MN, Fox NC, Collinge J, Schott JM, Mead S (2014). R47H TREM2 variant increases risk of typical early-onset Alzheimer's disease but not of prion or frontotemporal dementia.. Alzheimers Dement, , - . doi:10.1016/j.jalz.2014.05.1751
    • Macdonald KE, Leung KK, Bartlett JW, Blair M, Malone IB, Barnes J, Ourselin S, Fox NC, for the Alzheimer’s Disease Neuroimaging Initiative (2014). Automated Template-Based Hippocampal Segmentations from MRI: The Effects of 1.5T or 3T Field Strength on Accuracy.. Neuroinformatics, , - . doi:10.1007/s12021-013-9217-y
    • Paterson RW, Bartlett JW, Blennow K, Fox NC, Alzheimer's Disease Neuroimaging Initiative , Shaw LM, Trojanowski JQ, Zetterberg H, Schott JM (2014). Cerebrospinal fluid markers including trefoil factor 3 are associated with neurodegeneration in amyloid-positive individuals.. Transl Psychiatry, 4, e419 - . doi:10.1038/tp.2014.58
    • Ryan NS, Shakespeare TJ, Lehmann M, Keihaninejad S, Nicholas JM, Leung KK, Fox NC, Crutch SJ (2014). Motor features in posterior cortical atrophy and their imaging correlates.. Neurobiol Aging, , - . doi:10.1016/j.neurobiolaging.2014.05.028
    • Ryan NS, Shakespeare TJ, Lehmann M, Keihaninejad S, Nicholas JM, Leung KK, Fox NC, Crutch SJ (2014). Beyond visual deficits: motor features and associated atrophy patterns in posterior cortical atrophy.
    • Hill DL, Schwarz AJ, Isaac M, Pani L, Vamvakas S, Hemmings R, Carrillo MC, Yu P, Sun J, Beckett L, Boccardi M, Brewer J, Brumfield M, Cantillon M, Cole PE, Fox N, Frisoni GB, Jack C, Kelleher T, Luo F, Novak G, Maguire P, Meibach R, Patterson P, Bain L, Sampaio C, Raunig D, Soares H, Suhy J, Wang H, Wolz R, Stephenson D (2014). Coalition Against Major Diseases/European Medicines Agency biomarker qualification of hippocampal volume for enrichment of clinical trials in predementia stages of Alzheimer's disease.. Alzheimers Dement, 10(4), 421 - 429.e3. doi:10.1016/j.jalz.2013.07.003
    • Manning EN, Barnes J, Cash DM, Bartlett JW, Leung KK, Ourselin S, Nick C. Fox1 for the Alzheimer's Disease NeuroImaging Initiative (2014). APOE ε4 Is Associated with Disproportionate Progressive Hippocampal Atrophy in AD.. PLoS One, 9(5), e97608 - . doi:10.1371/journal.pone.0097608
    • Young AL, Oxtoby NP, Daga P, Cash DM, Fox NC, Ourselin S, Schott JM, Alexander DC, on behalf of the Alzheimer’s Disease Neuroimaging Initiative (2014). A data-driven model of biomarker changes in sporadic Alzheimer's disease.. Brain, , - . doi:10.1093/brain/awu176
    • Ferrari R, Hernandez DG, Nalls MA, Rohrer JD, Ramasamy A, Kwok JB, Dobson-Stone C, Brooks WS, Schofield PR, Halliday GM, Hodges JR, Piguet O, Bartley L, Thompson E, Haan E, Hernández I, Ruiz A, Boada M, Borroni B, Padovani A, Cruchaga C, Cairns NJ, Benussi L, Binetti G, Ghidoni R, Forloni G, Galimberti D, Fenoglio C, Serpente M, Scarpini E, Clarimón J, Lleó A, Blesa R, Waldö ML, Nilsson K, Nilsson C, Mackenzie IR, Hsiung GY, Mann DM, Grafman J, Morris CM, Attems J, Griffiths TD, McKeith IG, Thomas AJ, Pietrini P, Huey ED, Wassermann EM, Baborie A, Jaros E, Tierney MC, Pastor P, Razquin C, Ortega-Cubero S, Alonso E, Perneczky R, Diehl-Schmid J, Alexopoulos P, Kurz A, Rainero I, Rubino E, Pinessi L, Rogaeva E, St George-Hyslop P, Rossi G, Tagliavini F, Giaccone G, Rowe JB, Schlachetzki JC, Uphill J, Collinge J, Mead S, Danek A, Van Deerlin VM, Grossman M, Trojanowski JQ, van der Zee J, Deschamps W, Van Langenhove T, Cruts M, Van Broeckhoven C, Cappa SF, Le Ber I, Hannequin D, Golfier V, Vercelletto M, Brice A, Nacmias B, Sorbi S, Bagnoli S, Piaceri I, Nielsen JE, Hjermind LE, Riemenschneider M, Mayhaus M, Ibach B, Gasparoni G, Pichler S, Gu W, Rossor MN, Fox NC, Warren JD, Spillantini MG, Morris HR, Rizzu P, Heutink P, Snowden JS, Rollinson S, Richardson A, Gerhard A, Bruni AC, Maletta R, Frangipane F, Cupidi C, Bernardi L, Anfossi M, Gallo M, Conidi ME, Smirne N, Rademakers R, Baker M, Dickson DW, Graff-Radford NR, Petersen RC, Knopman D, Josephs KA, Boeve BF, Parisi JE, Seeley WW, Miller BL, Karydas AM, Rosen H, van Swieten JC, Dopper EG, Seelaar H, Pijnenburg YA, Scheltens P, Logroscino G, Capozzo R, Novelli V, Puca AA, Franceschi M, Postiglione A, Milan G, Sorrentino P, Kristiansen M, Chiang HH, Graff C, Pasquier F, Rollin A, Deramecourt V, Lebert F, Kapogiannis D, Ferrucci L, Pickering-Brown S, Singleton AB, Hardy J, Momeni P (2014). Frontotemporal dementia and its subtypes: a genome-wide association study.. Lancet Neurol, 13(7), 686 - 699. doi:10.1016/S1474-4422(14)70065-1
    • Ryman DC, Acosta-Baena N, Aisen PS, Bird T, Danek A, Fox NC, Goate A, Frommelt P, Ghetti B, Langbaum JB, Lopera F, Martins R, Masters CL, Mayeux RP, McDade E, Moreno S, Reiman EM, Ringman JM, Salloway S, Schofield PR, Sperling R, Tariot PN, Xiong C, Morris JC, Bateman RJ, And the Dominantly Inherited Alzheimer Network (2014). Symptom onset in autosomal dominant Alzheimer disease: A systematic review and meta-analysis.. Neurology, , - . doi:10.1212/WNL.0000000000000596
    • Escott-Price V, Bellenguez C, Wang LS, Choi SH, Harold D, Jones L, Holmans P, Gerrish A, Vedernikov A, Richards A, DeStefano AL, Lambert JC, Ibrahim-Verbaas CA, Naj AC, Sims R, Jun G, Bis JC, Beecham GW, Grenier-Boley B, Russo G, Thornton-Wells TA, Denning N, Smith AV, Chouraki V, Thomas C, Ikram MA, Zelenika D, Vardarajan BN, Kamatani Y, Lin CF, Schmidt H, Kunkle B, Dunstan ML, Vronskaya M, the United Kingdom Brain Expression Consortium , Johnson AD, Ruiz A, Bihoreau MT, Reitz C, Pasquier F, Hollingworth P, Hanon O, Fitzpatrick AL, Buxbaum JD, Campion D, Crane PK, Baldwin C, Becker T, Gudnason V, Cruchaga C, Craig D, Amin N, Berr C, Lopez OL, De Jager PL, Deramecourt V, Johnston JA, Evans D, Lovestone S, Letenneur L, Hernández I, Rubinsztein DC, Eiriksdottir G, Sleegers K, Goate AM, Fiévet N, Huentelman MJ, Gill M, Brown K, Kamboh MI, Keller L, Barberger-Gateau P, McGuinness B, Larson EB, Myers AJ, Dufouil C, Todd S, Wallon D, Love S, Rogaeva E, Gallacher J, George-Hyslop PS, Clarimon J, Lleo A, Bayer A, Tsuang DW, Yu L, Tsolaki M, Bossù P, Spalletta G, Proitsi P, Collinge J, Sorbi S, Garcia FS, Fox NC, Hardy J, Naranjo MC, Bosco P, Clarke R, Brayne C, Galimberti D, Scarpini E, Bonuccelli U, Mancuso M, Siciliano G, Moebus S, Mecocci P, Zompo MD, Maier W, Hampel H, Pilotto A, Frank-García A, Panza F, Solfrizzi V, Caffarra P, Nacmias B, Perry W, Mayhaus M, Lannfelt L, Hakonarson H, Pichler S, Carrasquillo MM, Ingelsson M, Beekly D, Alvarez V, Zou F, Valladares O, Younkin SG, Coto E, Hamilton-Nelson KL, Gu W, Razquin C, Pastor P, Mateo I, Owen MJ, Faber KM, Jonsson PV, Combarros O, O'Donovan MC, Cantwell LB, Soininen H, Blacker D, Mead S, Mosley TH, Bennett DA, Harris TB, Fratiglioni L, Holmes C, de Bruijn RF, Passmore P, Montine TJ, Bettens K, Rotter JI, Brice A, Morgan K, Foroud TM, Kukull WA, Hannequin D, Powell JF, Nalls MA, Ritchie K, Lunetta KL, Kauwe JS, Boerwinkle E, Riemenschneider M, Boada M, Hiltunen M, Martin ER, Schmidt R, Rujescu D, Dartigues JF, Mayeux R, Tzourio C, Hofman A, Nöthen MM, Graff C, Psaty BM, Haines JL, Lathrop M, Pericak-Vance MA, Launer LJ, Van Broeckhoven C, Farrer LA, van Duijn CM, Ramirez A, Seshadri S, Schellenberg GD, Amouyel P, Williams J (2014). Gene-Wide Analysis Detects Two New Susceptibility Genes for Alzheimer's Disease.. PLoS One, 9(6), e94661 - . doi:10.1371/journal.pone.0094661
    • Barnes J, Fox NC (2014). The search for early markers of AD: hippocampal atrophy and memory deficits.. Int Psychogeriatr, 26(7), 1065 - 1066. doi:10.1017/S1041610214000623
    • Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, DeKosky ST, Gauthier S, Selkoe D, Bateman R, Cappa S, Crutch S, Engelborghs S, Frisoni GB, Fox NC, Galasko D, Habert MO, Jicha GA, Nordberg A, Pasquier F, Rabinovici G, Robert P, Rowe C, Salloway S, Sarazin M, Epelbaum S, de Souza LC, Vellas B, Visser PJ, Schneider L, Stern Y, Scheltens P, Cummings JL (2014). Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.. Lancet Neurol, 13(6), 614 - 629. doi:10.1016/S1474-4422(14)70090-0
    • Chataway J, Schuerer N, Alsanousi A, Chan D, Macmanus D, Hunter K, Anderson V, Bangham CR, Clegg S, Nielsen C, Fox NC, Wilkie D, Nicholas JM, Calder VL, Greenwood J, Frost C, Nicholas R (2014). Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial.. Lancet, , - . doi:10.1016/S0140-6736(13)62242-4
    • Gallagher MD, Suh E, Grossman M, Elman L, McCluskey L, Van Swieten JC, Al-Sarraj S, Neumann M, Gelpi E, Ghetti B, Rohrer JD, Halliday G, Van Broeckhoven C, Seilhean D, Shaw PJ, Frosch MP, Alafuzoff I, Antonell A, Bogdanovic N, Brooks W, Cairns NJ, Cooper-Knock J, Cotman C, Cras P, Cruts M, De Deyn PP, Decarli C, Dobson-Stone C, Engelborghs S, Fox N, Galasko D, Gearing M, Gijselinck I, Grafman J, Hartikainen P, Hatanpaa KJ, Highley JR, Hodges J, Hulette C, Ince PG, Jin LW, Kirby J, Kofler J, Kril J, Kwok JB, Levey A, Lieberman A, Llado A, Martin JJ, Masliah E, McDermott CJ, McKee A, McLean C, Mead S, Miller CA, Miller J, Munoz DG, Murrell J, Paulson H, Piguet O, Rossor M, Sanchez-Valle R, Sano M, Schneider J, Silbert LC, Spina S, van der Zee J, Van Langenhove T, Warren J, Wharton SB, White Iii CL, Woltjer RL, Trojanowski JQ, Lee VM, Van Deerlin V, Chen-Plotkin AS (2014). TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions.. Acta Neuropathol, , - . doi:10.1007/s00401-013-1239-x
    • Mahoney CJ, Ridgway GR, Malone IB, Downey LE, Beck J, Kinnunen KM, Schmitz N, Golden HL, Rohrer JD, Schott JM, Rossor MN, Ourselin S, Mead S, Fox NC, Warren JD (2014). Profiles of white matter tract pathology in frontotemporal dementia.. Hum Brain Mapp, , - . doi:10.1002/hbm.22468
    • Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR, Bapineuzumab 301 and 302 Clinical Trial Investigators (2014). Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.. N Engl J Med, 370(4), 322 - 333. doi:10.1056/NEJMoa1304839
    • Thomas JB, Brier MR, Bateman RJ, Snyder AZ, Benzinger TL, Xiong C, Raichle M, Holtzman DM, Sperling RA, Mayeux R, Ghetti B, Ringman JM, Salloway S, McDade E, Rossor MN, Ourselin S, Schofield PR, Masters CL, Martins RN, Weiner MW, Thompson PM, Fox NC, Koeppe RA, Jack CR, Mathis CA, Oliver A, Blazey TM, Moulder K, Buckles V, Hornbeck R, Chhatwal J, Schultz AP, Goate AM, Fagan AM, Cairns NJ, Marcus DS, Morris JC, Ances BM (2014). Functional Connectivity in Autosomal Dominant and Late-Onset Alzheimer Disease.. JAMA Neurol, , - . doi:10.1001/jamaneurol.2014.1654

    2013

    • Chataway J, Schuerer N, Alsanousi A, Chan D, MacManus D, Hunter K, Anderson V, Foster J, Bangham C, Clegg S, Nielsen C, Fox N, Wilkie D, Nicholas J, Calder V, Greenwood J, Frost C, Nicholas R (2013). THE MS-STAT TRIAL: High Dose Simvastatin Slows Brain Atrophy and Delays Disability in Secondary Progressive Multiple Sclerosis: A Phase II Placebo-Controlled Trial.
    • Leung KK, Bartlett JW, Barnes J, Manning EN, Ourselin S, Fox NC, Alzheimer's Disease Neuroimaging Initiative (2013). Cerebral atrophy in mild cognitive impairment and Alzheimer disease: rates and acceleration.. Neurology, 80(7), 648 - 654. doi:10.1212/WNL.0b013e318281ccd3
    • Fox NC, Petersen RC (2013). The G8 Dementia Research Summit-a starter for eight?. LANCET, 382(9909), 1968 - 1969. doi:10.1016/S0140-6736(13)62426-5
    • Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C, Jun G, Destefano AL, Bis JC, Beecham GW, Grenier-Boley B, Russo G, Thornton-Wells TA, Jones N, Smith AV, Chouraki V, Thomas C, Ikram MA, Zelenika D, Vardarajan BN, Kamatani Y, Lin CF, Gerrish A, Schmidt H, Kunkle B, Dunstan ML, Ruiz A, Bihoreau MT, Choi SH, Reitz C, Pasquier F, Hollingworth P, Ramirez A, Hanon O, Fitzpatrick AL, Buxbaum JD, Campion D, Crane PK, Baldwin C, Becker T, Gudnason V, Cruchaga C, Craig D, Amin N, Berr C, Lopez OL, De Jager PL, Deramecourt V, Johnston JA, Evans D, Lovestone S, Letenneur L, Morón FJ, Rubinsztein DC, Eiriksdottir G, Sleegers K, Goate AM, Fiévet N, Huentelman MJ, Gill M, Brown K, Kamboh MI, Keller L, Barberger-Gateau P, McGuinness B, Larson EB, Green R, Myers AJ, Dufouil C, Todd S, Wallon D, Love S, Rogaeva E, Gallacher J, St George-Hyslop P, Clarimon J, Lleo A, Bayer A, Tsuang DW, Yu L, Tsolaki M, Bossù P, Spalletta G, Proitsi P, Collinge J, Sorbi S, Sanchez-Garcia F, Fox NC, Hardy J, Naranjo MC, Bosco P, Clarke R, Brayne C, Galimberti D, Mancuso M, Matthews F, European Alzheimer's Disease Initiative (EADI) , Genetic and Environmental Risk in Alzheimer's Disease (GERAD) , Alzheimer's Disease Genetic Consortium (ADGC) , Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) , Moebus S, Mecocci P, Del Zompo M, Maier W, Hampel H, Pilotto A, Bullido M, Panza F, Caffarra P, Nacmias B, Gilbert JR, Mayhaus M, Lannfelt L, Hakonarson H, Pichler S, Carrasquillo MM, Ingelsson M, Beekly D, Alvarez V, Zou F, Valladares O, Younkin SG, Coto E, Hamilton-Nelson KL, Gu W, Razquin C, Pastor P, Mateo I, Owen MJ, Faber KM, Jonsson PV, Combarros O, O'Donovan MC, Cantwell LB, Soininen H, Blacker D, Mead S, Mosley TH, Bennett DA, Harris TB, Fratiglioni L, Holmes C, de Bruijn RF, Passmore P, Montine TJ, Bettens K, Rotter JI, Brice A, Morgan K, Foroud TM, Kukull WA, Hannequin D, Powell JF, Nalls MA, Ritchie K, Lunetta KL, Kauwe JS, Boerwinkle E, Riemenschneider M, Boada M, Hiltunen M, Martin ER, Schmidt R, Rujescu D, Wang LS, Dartigues JF, Mayeux R, Tzourio C, Hofman A, Nöthen MM, Graff C, Psaty BM, Jones L, Haines JL, Holmans PA, Lathrop M, Pericak-Vance MA, Launer LJ, Farrer LA, van Duijn CM, Van Broeckhoven C, Moskvina V, Seshadri S, Williams J, Schellenberg GD, Amouyel P (2013). Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.. Nat Genet, , - . doi:10.1038/ng.2802
    • Toombs J, Paterson RW, Lunn MP, Nicholas JM, Fox NC, Chapman MD, Schott JM, Zetterberg H (2013). Identification of an important potential confound in CSF AD studies: aliquot volume.. Clin Chem Lab Med, , 1 - 7. doi:10.1515/cclm-2013-0293
    • Ahmed RM, Murphy E, Davagnanam I, Parton M, Schott JM, Mummery CJ, Rohrer JD, Lachmann RH, Houlden H, Fox NC, Chataway J (2013). A practical approach to diagnosing adult onset leucodystrophies.. J Neurol Neurosurg Psychiatry, , - . doi:10.1136/jnnp-2013-305888
    • Benzinger TL, Blazey T, Jack CR, Koeppe RA, Su Y, Xiong C, Raichle ME, Snyder AZ, Ances BM, Bateman RJ, Cairns NJ, Fagan AM, Goate A, Marcus DS, Aisen PS, Christensen JJ, Ercole L, Hornbeck RC, Farrar AM, Aldea P, Jasielec MS, Owen CJ, Xie X, Mayeux R, Brickman A, McDade E, Klunk W, Mathis CA, Ringman J, Thompson PM, Ghetti B, Saykin AJ, Sperling RA, Johnson KA, Salloway S, Correia S, Schofield PR, Masters CL, Rowe C, Villemagne VL, Martins R, Ourselin S, Rossor MN, Fox NC, Cash DM, Weiner MW, Holtzman DM, Buckles VD, Moulder K, Morris JC (2013). Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease.. Proc Natl Acad Sci U S A, , - . doi:10.1073/pnas.1317918110
    • Schofield PR, Bateman RJ, Xiong C, Benzinger TLS, Fagan AM, Goate A, Fox NC, Marcus DS, Cairns NJ, Xie X, Blazey TM, Holtzman DM, Santacruz A, Buckles V, Oliver A, Moulder K, Aisen PS, Ghetti B, Klunk WE, McDade E, Martins RN, Masters CL, Mayeux R, Ringman JM, Rossor MN, Sperling RA, Salloway S, Morris JC, DIAN (2013). CLINICAL AND BIOMARKER CHANGES IN DOMINANTLY INHERITED ALZHEIMER'S DISEASE. doi:10.1111/1440-1681.12170_5
    • Rossor M, Ahmed R, Liang Y, Douglas J, Mahoney C, Warren J, Schott J, Fox N (2013). LONGITUDINAL RESEARCH INTO ALZHEIMER'S DISEASE, FRONTO-TEMPORAL DEMENTIA AND OTHER DEMENTIAS.. J Neurol Neurosurg Psychiatry, 84(11), e2 - . doi:10.1136/jnnp-2013-306573.68
    • Mahoney C, Yeatman T, Rohrer J, Manning E, Leung K, Rossor M, Warren J, Fox N (2013). THE EVOLUTION OF FRONTOTEMPORAL DEMENTIA DUE TO THE MAPT MUTATION: A SEVENTEEN YEAR NATURAL HISTORY STUDY.. J Neurol Neurosurg Psychiatry, 84(11), e2 - . doi:10.1136/jnnp-2013-306573.86
    • Harper L, Barkhof F, Scheltens P, Schott JM, Fox NC (2013). An algorithmic approach to structural imaging in dementia.. J Neurol Neurosurg Psychiatry, , - . doi:10.1136/jnnp-2013-306285
    • Rohrer JD, Warren JD, Fox NC, Rossor MN (2013). Presymptomatic studies in genetic frontotemporal dementia.. Rev Neurol (Paris), , - . doi:10.1016/j.neurol.2013.07.010
    • Cash DM, Ridgway GR, Liang Y, Ryan NS, Kinnunen KM, Yeatman T, Malone IB, Benzinger TL, Jack CR, Thompson PM, Ghetti BF, Saykin AJ, Masters CL, Ringman JM, Salloway SP, Schofield PR, Sperling RA, Cairns NJ, Marcus DS, Xiong C, Bateman RJ, Morris JC, Rossor MN, Ourselin S, Fox NC, On behalf of the Dominantly Inherited Alzheimer Network (DIAN) (2013). The pattern of atrophy in familial Alzheimer disease: Volumetric MRI results from the DIAN study.. Neurology, , - . doi:10.1212/WNL.0b013e3182a841c6
    • Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, Lindley RI, O'Brien JT, Barkhof F, Benavente OR, Black SE, Brayne C, Breteler M, Chabriat H, Decarli C, de Leeuw FE, Doubal F, Duering M, Fox NC, Greenberg S, Hachinski V, Kilimann I, Mok V, Oostenbrugge RV, Pantoni L, Speck O, Stephan BC, Teipel S, Viswanathan A, Werring D, Chen C, Smith C, van Buchem M, Norrving B, Gorelick PB, Dichgans M, STandards for ReportIng Vascular changes on nEuroimaging (STRIVE v1) (2013). Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration.. Lancet Neurol, 12(8), 822 - 838. doi:10.1016/S1474-4422(13)70124-8
    • Liang Y, Gordon E, Rohrer J, Downey L, de Silva R, Jäger HR, Nicholas J, Modat M, Cardoso MJ, Mahoney C, Warren J, Rossor M, Fox N, Caine D (2013). A cognitive chameleon: Lessons from a novel MAPT mutation case.. Neurocase, , - . doi:10.1080/13554794.2013.826697
    • Beck J, Adamson G, Campbell T, Uphill J, Poulter M, Collinge J, Mead S, Pittman A, Houlden H, Shoai M, Hardy J, Kenny J, Rohrer JD, Mummery CJ, Warren JD, Schott JM, Fox NC, Rossor MN, de Silva R (2013). Validation of next-generation sequencing technologies in genetic diagnosis of dementia. Neurobiology of Aging, , - . doi:10.1016/j.neurobiolaging.2013.07.017
    • Vellas B, Carrillo MC, Sampaio C, Brashear HR, Siemers E, Hampel H, Schneider LS, Weiner M, Doody R, Khachaturian Z, Cedarbaum J, Grundman M, Broich K, Giacobini E, Dubois B, Sperling R, Wilcock GK, Fox N, Scheltens P, Touchon J, Hendrix S, Andrieu S, Aisen P, Members EUUSCTADTF (2013). Designing drug trials for Alzheimer's disease: What we have learned from the release of the phase III antibody trials: A report from the EU/US/CTAD Task Force. ALZHEIMERS & DEMENTIA, 9(4), 438 - 444. doi:10.1016/j.jalz.2013.03.007
    • Frisoni GB, Bocchetta M, Chételat G, Rabinovici GD, de Leon MJ, Kaye J, Reiman EM, Scheltens P, Barkhof F, Black SE, Brooks DJ, Carrillo MC, Fox NC, Herholz K, Nordberg A, Jack CR, Jagust WJ, Johnson KA, Rowe CC, Sperling RA, Thies W, Wahlund LO, Weiner MW, Pasqualetti P, Decarli C, For ISTAART's NeuroImaging Professional Interest Area (2013). Imaging markers for Alzheimer disease: Which vs how.. Neurology, 81(5), 487 - 500. doi:10.1212/WNL.0b013e31829d86e8
    • Rohrer JD, Beck J, Plagnol V, Gordon E, Lashley T, Revesz T, Janssen JC, Fox NC, Warren JD, Rossor MN, Mead S, Schott JM (2013). Exome sequencing reveals a novel partial deletion in the progranulin gene causing primary progressive aphasia.. J Neurol Neurosurg Psychiatry, , - . doi:10.1136/jnnp-2013-306116
    • Warren JD, Rohrer JD, Schott JM, Fox NC, Hardy J, Rossor MN (2013). Molecular nexopathies: a new paradigm of neurodegenerative disease.. Trends Neurosci, , - . doi:10.1016/j.tins.2013.06.007
    • Chhatwal JP, Schultz AP, Johnson K, Benzinger TL, Jack C, Ances BM, Sullivan CA, Salloway SP, Ringman JM, Koeppe RA, Marcus DS, Thompson P, Saykin AJ, Correia S, Schofield PR, Rowe CC, Fox NC, Brickman AM, Mayeux R, McDade E, Bateman R, Fagan AM, Goate AM, Xiong C, Buckles VD, Morris JC, Sperling RA (2013). Impaired default network functional connectivity in autosomal dominant Alzheimer disease.. Neurology, , - . doi:10.1212/WNL.0b013e3182a1aafe
    • Guerreiro R, Kara E, Le Ber I, Bras J, Rohrer JD, Taipa R, Lashley T, Dupuits C, Gurunlian N, Mochel F, Warren JD, Hannequin D, Sedel F, Depienne C, Camuzat A, Golfier V, Du Boisguéheneuc F, Schottlaender L, Fox NC, Beck J, Mead S, Rossor MN, Hardy J, Revesz T, Brice A, Houlden H (2013). Genetic analysis of inherited leukodystrophies: genotype-phenotype correlations in the CSF1R gene.. JAMA Neurol, 70(7), 875 - 882. doi:10.1001/jamaneurol.2013.698
    • Ryan NS, Fox NC (2013). Reply: Implications of presymptomatic change in thalamus and caudate in Alzheimer's disease.. Brain, , - . doi:10.1093/brain/awt168
    • Wyman BT, Harvey DJ, Crawford K, Bemstein MA, Carmichael O, Cole PE, Crane PK, DeCarli C, Fox NC, Gunter JL, Hill D, Killiany RJ, Pachai C, Schwarz AJ, Schuff N, Senjem ML, Suhy J, Thompson PM, Weiner M, Jr JCR, Initi ADN (2013). Standardization of analysis sets for reporting results from ADNI MRI data. ALZHEIMERS & DEMENTIA, 9(3), 332 - 337. doi:10.1016/j.jalz.2012.06.004
    • Massey LA, Jäger HR, Paviour DC, O'Sullivan SS, Ling H, Williams DR, Kallis C, Holton J, Revesz T, Burn DJ, Yousry T, Lees AJ, Fox NC, Micallef C (2013). The midbrain to pons ratio: a simple and specific MRI sign of progressive supranuclear palsy.. Neurology, 80(20), 1856 - 1861. doi:10.1212/WNL.0b013e318292a2d2
    • Andrews KA, Modat M, Macdonald KE, Yeatman T, Cardoso MJ, Leung KK, Barnes J, Villemagne VL, Rowe CC, Fox NC, Ourselin S, Schott JM, the Australian Imaging Biomarkers , Lifestyle Flagship Study of Ageing (2013). Atrophy Rates in Asymptomatic Amyloidosis: Implications for Alzheimer Prevention Trials. PLoS ONE, 8(3), e58816 - . doi:10.1371/journal.pone.0058816
    • Ryan NS, Keihaninejad S, Shakespeare TJ, Lehmann M, Crutch SJ, Malone IB, Thornton JS, Mancini L, Hyare H, Yousry T, Ridgway GR, Zhang H, Modat M, Alexander DC, Rossor MN, Ourselin S, Fox NC (2013). Magnetic resonance imaging evidence for presymptomatic change in thalamus and caudate in familial Alzheimer's disease.. Brain, 136(Pt 5), 1399 - 1414. doi:10.1093/brain/awt065
    • Barnes J, Carmichael OT, Leung KK, Schwarz C, Ridgway GR, Bartlett JW, Malone IB, Schott JM, Rossor MN, Biessels GJ, DeCarli C, Fox NC, Alzheimer's Disease Neuroimaging Initiative (2013). Vascular and Alzheimer's disease markers independently predict brain atrophy rate in Alzheimer's Disease Neuroimaging Initiative controls.. Neurobiol Aging, 34(8), 1996 - 2002. doi:10.1016/j.neurobiolaging.2013.02.003
    • Jorge Cardoso M, Leung K, Modat M, Keihaninejad S, Cash D, Barnes J, Fox NC, Ourselin S, Alzheimer’s Disease Neuroimaging Initiative (2013). STEPS: Similarity and Truth Estimation for Propagated Segmentations and its application to hippocampal segmentation and brain parcelation.. Med Image Anal, 17(6), 671 - 684. doi:10.1016/j.media.2013.02.006
    • Bartolome F, Wu HC, Burchell VS, Preza E, Wray S, Mahoney CJ, Fox NC, Calvo A, Canosa A, Moglia C, Mandrioli J, Chiò A, Orrell RW, Houlden H, Hardy J, Abramov AY, Plun-Favreau H (2013). Pathogenic VCP mutations induce mitochondrial uncoupling and reduced ATP levels.. Neuron, 78(1), 57 - 64. doi:10.1016/j.neuron.2013.02.028
    • Beck J, Poulter M, Hensman D, Rohrer JD, Mahoney CJ, Adamson G, Campbell T, Uphill J, Borg A, Fratta P, Orrell RW, Malaspina A, Rowe J, Brown J, Hodges J, Sidle K, Polke JM, Houlden H, Schott JM, Fox NC, Rossor MN, Tabrizi SJ, Isaacs AM, Hardy J, Warren JD, Collinge J, Mead S (2013). Large C9orf72 hexanucleotide repeat expansions are seen in multiple neurodegenerative syndromes and are more frequent than expected in the UK population.. Am J Hum Genet, 92(3), 345 - 353. doi:10.1016/j.ajhg.2013.01.011
    • Foster NL, Jagust WJ, Fox NC (2013). A peek behind the curtain: amyloid imaging, referrals, and specialist memory evaluations.. Alzheimer Dis Assoc Disord, 27(1), 1 - 3. doi:10.1097/WAD.0b013e31828ab5d8
    • Rohrer JD, Caso F, Mahoney C, Henry M, Rosen HJ, Rabinovici G, Rossor MN, Miller B, Warren JD, Fox NC, Ridgway GR, Gorno-Tempini ML (2013). Patterns of longitudinal brain atrophy in the logopenic variant of primary progressive aphasia.. Brain Lang, 127(2), 121 - 126. doi:10.1016/j.bandl.2012.12.008
    • Scahill RI, Ridgway GR, Barnes J, Ryan NS, Clarkson MJ, Foster J, Crutch SJ, Schott JM, Ourselin S, Warren JD, Hardy J, Rossor MN, Fox NC (2013). Genetic influences on atrophy patterns in familial AD: a comparason of APP and PSEN-1 mutations. Journal of AD, 35, 199 - 212. doi:10.3233/JAD-121255
    • Lehmann M, Koedam EL, Barnes J, Bartlett JW, Barkhof F, Wattjes MP, Schott JM, Scheltens P, Fox NC, Alzheimer's Disease Neuroimaging Initiative (2013). Visual ratings of atrophy in MCI: prediction of conversion and relationship with CSF biomarkers.. Neurobiol Aging, 34(1), 73 - 82. doi:10.1016/j.neurobiolaging.2012.03.010
    • Liang Y, Ryan NS, Schott JM, Fox NC (2013). Imaging the onset and progression of Alzheimer's disease: implications for prevention trials.. J Alzheimers Dis, 33 Suppl 1, S305 - S312. doi:10.3233/JAD-2012-129010
    • Barnes J, Bartlett JW, Fox NC, Schott JM (2013). Targeted recruitment using cerebrospinal fluid biomarkers: implications for Alzheimer's disease therapeutic trials.. J Alzheimers Dis, 34(2), 431 - 437. doi:10.3233/JAD-121936
    • Malone IB, Cash D, Ridgway GR, MacManus DG, Ourselin S, Fox NC, Schott JM (2013). MIRIAD--Public release of a multiple time point Alzheimer's MR imaging dataset.. Neuroimage, 70, 33 - 36. doi:10.1016/j.neuroimage.2012.12.044
    • Crutch SJ, Schott JM, Rabinovici GD, Boeve BF, Cappa SF, Dickerson BC, Dubois B, Graff-Radford NR, Krolak-Salmon P, Lehmann M, Mendez MF, Pijnenburg Y, Ryan NS, Scheltens P, Shakespeare T, Tang-Wai DF, van der Flier WM, Bain L, Carrillo MC, Fox NC (2013). Shining a light on posterior cortical atrophy.. Alzheimers Dement, 9(4), 463 - 465. doi:10.1016/j.jalz.2012.11.004
    • Keihaninejad S, Zhang H, Ryan NS, Malone IB, Modat M, Cardoso J, Cash D, Fox NC, Ourselin S (2013). An unbiased longitudinal analysis framework for tracking white matter changes using diffusion tensor imaging with application to Alzheimer's disease. NeuroImage, , - . doi:10.1016/j.neuroimage.2013.01.044
    • Mahoney CJ, Malone IB, Ridgway GR, Buckley AH, Downey LE, Golden HL, Ryan NS, Ourselin S, Schott JM, Rossor MN, Fox NC, Warren JD (2013). White matter tract signatures of the progressive aphasias.. Neurobiol Aging, 34(6), 1687 - 1699. doi:10.1016/j.neurobiolaging.2012.12.002
    • Rascovsky K, Hodges J, Knopman D, Mendez M, Kramer J, Neuhaus J, Van Swieten J, Seelaar H, Dopper E, Onyike C, Hillis A, Josephs K, Boeve B, Kertesz A, Seeley W, Rankin K, Johnson J, Tempini MG, Rosen H, Latham C, Lee A, Kipps C, Lillo P, Piguet O, Rohrer J, Rossor M, Warren J, Fox N, Galasko D, Salmon D, Black S, Mesulam M, Weintraub S, Dickerson B, Diehl J, Pasquier F, Deramecourt V, Lebert F, Pijnenburg Y, Chow T, Manes F, Grafman J, Cappa S, Freedman M, Miller B, Grossman M (2013). Can Clinical Features Predict Tau Pathology in Patients with Behavioral Variant Frontotemporal Dementia (bvFTD)?.

    2012

    • Modat M, Leung KK, Cardoso MJ, Fox NC (2012). Atrophy Measurement Based on Segmentation Propagation and the Boundary Shift Integral Technique.
    • Filippi M, Agosta F, Barkhof F, Dubois B, Fox NC, Frisoni GB, Jack CR, Johannsen P, Miller BL, Nestor PJ, Scheltens P, Sorbi S, Teipel S, Thompson PM, Wahlund L-O (2012). EFNS task force: the use of neuroimaging in the diagnosis of dementia. EUROPEAN JOURNAL OF NEUROLOGY, 19(12), 1487 - E140. doi:10.1111/j.1468-1331.2012.03859.x
    • Lehmann M, Barnes J, Ridgway GR, Ryan NS, Warrington EK, Crutch SJ, Fox NC (2012). Global gray matter changes in posterior cortical atrophy: A serial imaging study. Alzheimer's and Dementia, , - .
    • Lehmann M, Koedam EL, Barnes J, Bartlett JW, Ryan NS, Pijnenburg YA, Barkhof F, Wattjes MP, Scheltens P, Fox NC (2012). Posterior cerebral atrophy in the absence of medial temporal lobe atrophy in pathologically-confirmed Alzheimer's disease.. Neurobiol Aging, 33(3), 627.e1 - 627.e12. doi:10.1016/j.neurobiolaging.2011.04.003
    • Ryan NS, Bastos-Leite AJ, Rohrer JD, Werring DJ, Fox NC, Rossor MN, Schott JM (2012). Cerebral microbleeds in familial Alzheimer's disease.. Brain, 135(Pt 1), e201 - . doi:10.1093/brain/awr126
    • Alner K, Hyare H, Mead S, Rudge P, Wroe S, Rohrer JD, Ridgway GR, Ourselin S, Clarkson M, Hunt H, Fox NC, Webb T, Collinge J, Cipolotti L (2012). Distinct neuropsychological profiles correspond to distribution of cortical thinning in inherited prion disease caused by insertional mutation.. J Neurol Neurosurg Psychiatry, 83(1), 109 - 114. doi:10.1136/jnnp-2011-300167
    • Gerrish A, Russo G, Richards A, Moskvina V, Ivanov D, Harold D, Sims R, Abraham R, Hollingworth P, Chapman J, Hamshere M, Pahwa JS, Dowzell K, Williams A, Jones N, Thomas C, Stretton A, Morgan AR, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Morgan K, Brown KS, Passmore PA, Craig D, McGuinness B, Todd S, Johnston JA, Holmes C, Mann D, Smith AD, Love S, Kehoe PG, Hardy J, Mead S, Fox N, Rossor M, Collinge J, Maier W, Jessen F, Kölsch H, Heun R, Schürmann B, van den Bussche H, Heuser I, Kornhuber J, Wiltfang J, Dichgans M, Frölich L, Hampel H, Hüll M, Rujescu D, Goate AM, Kauwe JS, Cruchaga C, Nowotny P, Morris JC, Mayo K, Livingston G, Bass NJ, Gurling H, McQuillin A, Gwilliam R, Deloukas P, Davies G, Harris SE, Starr JM, Deary IJ, Al-Chalabi A, Shaw CE, Tsolaki M, Singleton AB, Guerreiro R, Mühleisen TW, Nöthen MM, Moebus S, Jöckel KH, Klopp N, Wichmann HE, Carrasquillo MM, Pankratz VS, Younkin SG, Jones L, Holmans PA, O'Donovan MC, Owen MJ, Williams J (2012). The role of variation at AβPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's disease.. J Alzheimers Dis, 28(2), 377 - 387. doi:10.3233/JAD-2011-110824
    • Leung KK, Ridgway GR, Ourselin S, Fox NC, Alzheimer's Disease Neuroimaging Initiative (2012). Consistent multi-time-point brain atrophy estimation from the boundary shift integral.. Neuroimage, 59(4), 3995 - 4005. doi:10.1016/j.neuroimage.2011.10.068
    • Bateman RJ, Xiong C, Benzinger TLS, Fagan AM, Goate A, Fox NC, Marcus DS, Cairns NJ, Xie X, Blazey TM, others (2012). Clinical and biomarker changes in dominantly inherited alzheimer’s disease. New England Journal of Medicine, , - .
    • Massey LA, Micallef C, Paviour DC, O'Sullivan SS, Ling H, Williams DR, Kallis C, Holton JL, Revesz T, Burn DJ, Yousry T, Lees AJ, Fox NC, Jäger HR (2012). Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophy. Movement Disorders, , - .
    • Cash DM, Melbourne A, Modat M, Machado M, Clarkson M, Fox N, Ourselin S (2012). Cortical Folding Analysis on Patients with Alzheimer’s Disease and Mild Cognitive Impairment. doi:10.1007/978-3-642-33454-2_36
    • Mahoney CJ, Beck J, Rohrer JD, Lashley T, Mok K, Shakespeare T, Yeatman T, Warrington EK, Schott JM, Fox NC, Rossor MN, Hardy J, Collinge J, Revesz T, Mead S, Warren JD (2012). Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features.. Brain, 135(Pt 3), 736 - 750. doi:10.1093/brain/awr361
    • Cardoso MJ, Wolz R, Modat M, Fox NC, Rueckert D, Ourselin S (2012). Geodesic information flows..
    • Lehmann M, Barnes J, Ridgway GR, Ryan NS, Warrington EK, Crutch SJ, Fox NC (2012). Global gray matter changes in posterior cortical atrophy: a serial imaging study.. Alzheimers Dement, 8(6), 502 - 512. doi:10.1016/j.jalz.2011.09.225
    • Mahoney C, Downey L, Ridgway G, Beck J, Clegg S, Blair M, Finnegan S, Leung K, Yeatman T, Golden H, Mead S, Rohrer J, Fox N, Warren J (2012). Longitudinal neuroimaging and neuropsychological profiles of frontotemporal dementia with C9ORF72 expansions. Alzheimer's Research & Therapy, 4(5), 41 - . doi:10.1186/alzrt144
    • Wilkinson D, Fox NC, Barkhof F, Phul R, Lemming O, Scheltens P, Investigators S1 (2012). Memantine and Brain Atrophy in Alzheimer's Disease: A 1-Year Randomized Controlled Trial. JOURNAL OF ALZHEIMERS DISEASE, 29(2), 459 - 469. doi:10.3233/JAD-2011-111616
    • Fonteijn HM, Modat M, Clarkson MJ, Barnes J, Lehmann M, Hobbs NZ, Scahill RI, Tabrizi SJ, Ourselin S, Fox NC, Alexander DC (2012). An event-based model for disease progression and its application in familial Alzheimer's disease and Huntington's disease.. Neuroimage, 60(3), 1880 - 1889. doi:10.1016/j.neuroimage.2012.01.062
    • Crutch SJ, Lehmann M, Schott JM, Rabinovici GD, Rossor MN, Fox NC (2012). Posterior cortical atrophy.. Lancet Neurol, 11(2), 170 - 178. doi:10.1016/S1474-4422(11)70289-7
    • Sperling R, Salloway S, Brooks DJ, Tampieri D, Barakos J, Fox NC, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Lieberburg I, Arrighi HM, Morris KA, Lu Y, Liu E, Gregg KM, Brashear HR, Kinney GG, Black R, Grundman M (2012). Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis. LANCET NEUROLOGY, 11(3), 241 - 249. doi:10.1016/S1474-4422(12)70015-7
    • Mahoney C, Rossor MN, Fox NC, Warren JD (2012). PROFILES OF WHITE MATTER DEGENERATION IN FRONTOTEMPORAL DEMENTIA. doi:10.1136/jnnp-2011-301993.61
    • Rohrer JD, Clarkson MJ, Kittus R, Rossor MN, Ourselin S, Warren JD, Fox NC (2012). Rates of hemispheric and lobar atrophy in the language variants of frontotemporal lobar degeneration.. J Alzheimers Dis, 30(2), 407 - 411. doi:10.3233/JAD-2012-111556
    • Johnson KA, Fox NC, Sperling RA, Klunk WE (2012). Brain Imaging in Alzheimer Disease. COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 4(4), - . doi:10.1101/cshperspect.a006213
    • Fox N (2012). MRI IN THE EVALUATION OF THERAPEUTIC EFFECTS IN CLINICAL TRIALS IN EARLY AND PRESYMPTOMATIC AD.
    • Ridgway GR, Lehmann M, Barnes J, Rohrer JD, Warren JD, Crutch SJ, Fox NC (2012). Early-onset Alzheimer disease clinical variants: multivariate analyses of cortical thickness.. Neurology, 79(1), 80 - 84. doi:10.1212/WNL.0b013e31825dce28
    • Keihaninejad S, Ryan N, Malone IB, Modat M, Cash DM, Ridgway G, Zhang H, Fox N, Ourselin S (2012). The importance of group-wise registration in Tract Based Spatial Statistics study of neurodegeneration: A simulation study in Alzheimer’s disease. PLoS One, 7(11), - . doi:10.1371/journal.pone.0045996
    • Fox N (2012). When, where, and how does Alzheimer's disease start?. Lancet Neurol, 11(12), 1017 - 1018. doi:10.1016/S1474-4422(12)70256-9
    • Johnson KA, Fox NC, Sperling RA, Klunk WE (2012). Brain Imaging in Alzheimer Disease. COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2(4), - . doi:10.1101/cshperspect.a006213

    2011

    • Lehmann M, Crutch SJ, Ridgway GR, Ridha BH, Barnes J, Warrington EK, Rossor MN, Fox NC (2011). Cortical thickness and voxel-based morphometry in posterior cortical atrophy and typical Alzheimer's disease.. Neurobiol Aging, 32(8), 1466 - 1476. doi:10.1016/j.neurobiolaging.2009.08.017
    • Koedam ELGE, Lehmann M, van der Flier WM, Scheltens P, Pijnenburg YAL, Fox N, Barkhof F, Wattjes MP (2011). Visual assessment of posterior atrophy development of a MRI rating scale. EUROPEAN RADIOLOGY, 21(12), 2618 - 2625. doi:10.1007/s00330-011-2205-4
    • Rohrer JD, Lashley T, Holton J, Revesz T, Urwin H, Isaacs AM, Fox NC, Rossor MN, Warren J (2011). The clinical and neuroanatomical phenotype of FUS associated frontotemporal lobar degeneration.. J Neurol Neurosurg Psychiatry, 82(12), 1405 - 1407. doi:10.1136/jnnp.2010.214437
    • Stevens JC, Beck J, Lukic A, Ryan N, Abbs S, Collinge J, Fox NC, Mead S (2011). Familial Alzheimer's disease and inherited prion disease in the UK are poorly ascertained.. J Neurol Neurosurg Psychiatry, 82(9), 1054 - 1057. doi:10.1136/jnnp.2009.199653
    • Knight WD, Okello AA, Ryan NS, Turkheimer FE, Rodríguez Martinez de Llano S, Edison P, Douglas J, Fox NC, Brooks DJ, Rossor MN (2011). Carbon-11-Pittsburgh compound B positron emission tomography imaging of amyloid deposition in presenilin 1 mutation carriers.. Brain, 134(Pt 1), 293 - 300. doi:10.1093/brain/awq310
    • Clarkson MJ, Cardoso MJ, Ridgway GR, Modat M, Leung KK, Rohrer JD, Fox NC, Ourselin S (2011). A comparison of voxel and surface based cortical thickness estimation methods. NeuroImage, 57(3), 856 - 865. doi:10.1016/j.neuroimage.2011.05.053
    • Fonteijn HM, Alexander DC, Clarkson MJ, Modat M, Ourselin S, Barnes J, Lehmann M, Fox NC (2011). An event-based disease progression model and its application to familial Alzheimer's disease. doi:10.1007/978-3-642-22092-0_61
    • Leung KK, Barnes J, Modat M, Ridgway GR, Bartlett J, Fox NC, Ourselin S (2011). Automated brain extraction using multi-atlas propagation and segmentation (MAPS). doi:10.1109/ISBI.2011.5872816
    • Bateman RJ, Aisen PS, De Strooper B, Fox NC, Lemere CA, Ringman JM, Salloway S, Sperling RA, Windisch M, Xiong C (2011). Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease. ALZHEIMERS RESEARCH & THERAPY, 3(1), - . doi:10.1186/alzrt59
    • Tabrizi SJ, Scahill RI, Durr A, Roos RA, Leavitt BR, Jones R, Landwehrmeyer GB, Fox NC, Johnson H, Hicks SL, Kennard C, Craufurd D, Frost C, Langbehn DR, Reilmann R, Stout JC, TRACK-HD Investigators (2011). Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis.. Lancet Neurol, 10(1), 31 - 42. doi:10.1016/S1474-4422(10)70276-3
    • Leung KK, Barnes J, Modat M, Ridgway GR, Bartlett JW, Fox NC, Ourselin S (2011). Brain MAPS: An automated, accurate and robust brain extraction technique using a template library. NeuroImage, , - .
    • Leung KK, Barnes J, Modat M, Ridgway GR, Bartlett JW, Fox NC, Ourselin S, Alzheimer's Disease Neuroimaging Initiative (2011). Brain MAPS: an automated, accurate and robust brain extraction technique using a template library.. Neuroimage, 55(3), 1091 - 1108. doi:10.1016/j.neuroimage.2010.12.067
    • Rohrer JD, Lashley T, Schott JM, Warren JE, Mead S, Isaacs AM, Beck J, Hardy J, de Silva R, Warrington E, Troakes C, Al-Sarraj S, King A, Borroni B, Clarkson M, Ourselin S, Holton J, Fox NC, Revesz T, Rossor MN, Warren JD (2011). Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration. Brain, 134(9), 2565 - 2581.
    • Anderson V, Schott J, Bartlett J, Leung KK, Miller DH, Fox NC (2011). Grey matter atrophy rate as a marker of disease progression in AD. Neurobiology of Aging, , - . doi:10.1016/j.neurobiolaging.2010.11.001
    • Lehmann M, Rohrer JD, Clarkson MJ, Ridgway GR, Scahill RI, Warren JD, Ourselin S, Barnes J, Rossor MN, Fox NC, Modat M (2011). Patterns of cortical thickness in pathologically-confirmed typical and atypical Alzheimer's disease. In (Ed.), (pp. 57 - 67). : . doi:10.3233/978-1-60750-793-2-57
    • Schott JM, Warren JD, Barkhof F, Rossor MN, Fox NC (2011). Suspected early dementia.. BMJ, 343, d5568 - .
    • Kennedy J, Lehmann M, Sokolska MJ, Archer H, Warrington EK, Fox NC, Crutch SJ (2011). Visualizing the emergence of posterior cortical atrophy. Neurocase, , - . doi:10.1080/13554794.2011.588180
    • Fox NC, Ridgway GR, Schott JM (2011). Algorithms, atrophy and Alzheimer's disease: cautionary tales for clinical trials.. Neuroimage, 57(1), 15 - 18. doi:10.1016/j.neuroimage.2011.01.077
    • Lehmann M, Barnes J, Ridgway GR, Wattam-Bell J, Warrington EK, Fox NC, Crutch SJ (2011). Basic visual function and cortical thickness patterns in posterior cortical atrophy.. Cereb Cortex, 21(9), 2122 - 2132. doi:10.1093/cercor/bhq287
    • Cardoso MJ, Clarkson MJ, Ridgway GR, Modat M, Fox NC, Ourselin S, Alzheimer's Disease Neuroimaging Initiative (2011). LoAd: a locally adaptive cortical segmentation algorithm.. Neuroimage, 56(3), 1386 - 1397. doi:10.1016/j.neuroimage.2011.02.013
    • van der Flier WM, Pijnenburg YAL, Fox NC, Scheltens P (2011). Early-onset versus late-onset Alzheimer's disease: the case of the missing APOE epsilon 4 allele. LANCET NEUROL, 10(3), 280 - 288. doi:10.1016/S1474-4422(10)70306-9
    • Clarkson MJ, Cardoso M, Modat M, Ridgway GR, Leung KK, Rohrer J, Fox NC, Ourselin S (2011). Cross-sectional analysis using voxel or surface based cortical thickness methods: a comparison study. doi:10.1109/ISBI.2011.5872428
    • Hollingworth P, Harold D, Sims R, Gerrish A, Lambert JC, Carrasquillo MM, Abraham R, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Jones N, Stretton A, Thomas C, Richards A, Ivanov D, Widdowson C, Chapman J, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Brown KS, Passmore PA, Craig D, McGuinness B, Todd S, Holmes C, Mann D, Smith AD, Beaumont H, Warden D, Wilcock G, Love S, Kehoe PG, Hooper NM, Vardy ER, Hardy J, Mead S, Fox NC, Rossor M, Collinge J, Maier W, Jessen F, Rüther E, Schürmann B, Heun R, Kölsch H, van den Bussche H, Heuser I, Kornhuber J, Wiltfang J, Dichgans M, Frölich L, Hampel H, Gallacher J, Hüll M, Rujescu D, Giegling I, Goate AM, Kauwe JS, Cruchaga C, Nowotny P, Morris JC, Mayo K, Sleegers K, Bettens K, Engelborghs S, De Deyn PP, Van Broeckhoven C, Livingston G, Bass NJ, Gurling H, McQuillin A, Gwilliam R, Deloukas P, Al-Chalabi A, Shaw CE, Tsolaki M, Singleton AB, Guerreiro R, Mühleisen TW, Nöthen MM, Moebus S, Jöckel KH, Klopp N, Wichmann HE, Pankratz VS, Sando SB, Aasly JO, Barcikowska M, Wszolek ZK, Dickson DW, Graff-Radford NR, Petersen RC, Alzheimer's Disease Neuroimaging Initiative , van Duijn CM, Breteler MM, Ikram MA, DeStefano AL, Fitzpatrick AL, Lopez O, Launer LJ, Seshadri S, CHARGE consortium , Berr C, Campion D, Epelbaum J, Dartigues JF, Tzourio C, Alpérovitch A, Lathrop M, EADI1 consortium , Feulner TM, Friedrich P, Riehle C, Krawczak M, Schreiber S, Mayhaus M, Nicolhaus S, Wagenpfeil S, Steinberg S, Stefansson H, Stefansson K, Snaedal J, Björnsson S, Jonsson PV, Chouraki V, Genier-Boley B, Hiltunen M, Soininen H, Combarros O, Zelenika D, Delepine M, Bullido MJ, Pasquier F, Mateo I, Frank-Garcia A, Porcellini E, Hanon O, Coto E, Alvarez V, Bosco P, Siciliano G, Mancuso M, Panza F, Solfrizzi V, Nacmias B, Sorbi S, Bossù P, Piccardi P, Arosio B, Annoni G, Seripa D, Pilotto A, Scarpini E, Galimberti D, Brice A, Hannequin D, Licastro F, Jones L, Holmans PA, Jonsson T, Riemenschneider M, Morgan K, Younkin SG, Owen MJ, O'Donovan M, Amouyel P, Williams J (2011). Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease.. Nat Genet, 43(5), 429 - 435. doi:10.1038/ng.803
    • Mahoney CJ, Rohrer JD, Goll JC, Fox NC, Rossor MN, Warren JD (2011). Structural neuroanatomy of tinnitus and hyperacusis in semantic dementia.. J Neurol Neurosurg Psychiatry, 82(11), 1274 - 1278. doi:10.1136/jnnp.2010.235473
    • Seelaar H, Rohrer JD, Pijnenburg YAL, Fox NC, van Swieten JC (2011). Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review. J NEUROL NEUROSUR PS, 82(5), 476 - 486. doi:10.1136/jnnp.2010.212225
    • Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH (2011). The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. ALZHEIMERS DEMENT, 7(3), 270 - 279. doi:10.1016/j.jalz.2011.03.008
    • Jack CR, Barkhof F, Bernstein MA, Cantillon M, Cole PE, DeCarli C, Dubois B, Duchesne S, Fox NC, Frisoni GB, Hampel H, Hill DLG, Johnson K, Mangin JF, Scheltens P, Schwarz AJ, Sperling R, Suhy J, Thompson PM, Weiner M, Foster NL (2011). Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer's disease. ALZHEIMERS DEMENT, 7(4), 474 - 485. doi:10.1016/j.jalz.2011.04.007
    • Barnes J, Carmichael O, Leung K, Schwarz C, Ridgway G, Bartlett J, Malone I, Schott J, Rossor M, Biessels G-J, DeCarli C, Fox N (2011). The independent effects of white matter hyperintensity volume and cerebrospinal fluid amyloid levels on brain atrophy. doi:10.1016/j.jalz.2011.05.014
    • Lashley T, Rohrer JD, Bandopadhyay R, Fry C, Ahmed Z, Isaacs AM, Brelstaff JH, Borroni B, Warren JD, Troakes C, King A, Al-Saraj S, Newcombe J, Quinn N, Ostergaard K, Schrøder HD, Bojsen-Møller M, Braendgaard H, Fox NC, Rossor MN, Lees AJ, Holton JL, Revesz T (2011). A comparative clinical, pathological, biochemical and genetic study of fused in sarcoma proteinopathies.. Brain, 134(Pt 9), 2548 - 2564. doi:10.1093/brain/awr160
    • Clarkson MJ, Cardoso MJ, Modat M, Ridgway GR, Leung KK, Rohrer JD, Ourselin S, Fox N (2011). A Comparative Study of Voxel and Surface Based Cortical Thickness Methods in Frontotemporal Dementia.
    • Leung KK, Ridgway GR, Clarkson MJ, Nielsen C, Ourselin S, Fox N (2011). Automated and consistent brain atrophy estimation using boundary shift integral in longitudinal MRI study.
    • Ridgway GR, Lehmann M, Rohrer J, Clarkson M, Warren J, Ourselin S, Fox N (2011). Balanced sensitivity and specificity on unbalanced data using support vector machine re-thresholding.
    • Ridgway GR, Barnes J, Pepple T, Fox N (2011). Estimation of total intracranial volume - a comparison of methods.
    • Sims R, Dwyer S, Harold D, Gerrish A, Hollingworth P, Chapman J, Jones N, Abraham R, Ivanov D, Pahwa JS, Moskvina V, Dowzell K, Thomas C, Stretton A, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Morgan K, Brown KS, Passmore PA, Craig D, McGuiness B, Todd S, Johnston JA, Holmes C, Mann D, Smith AD, Love S, Kehoe PG, Hardy J, Mead S, Fox N, Rossor M, Collinge J, Livingston G, Bass NJ, Gurling H, McQuillin A, Jones L, Holmans PA, O'Donovan M, Owen MJ, Williams J (2011). No evidence that extended tracts of homozygosity are associated with Alzheimer's disease.. Am J Med Genet B Neuropsychiatr Genet, 156B(7), 764 - 771. doi:10.1002/ajmg.b.31216
    • Ryan N, Rossor MN, Fox NC (2011). CHARACTERISING THE CLINICAL PHENOTYPE OF FAMILIAL ALZHEIMER'S DISEASE (FAD). J NEUROL NEUROSUR PS, 82(9), - . doi:10.1136/jnnp-2011-300645.1
    • Mahoney CJ, Buckley AH, Fox NC, Warren JD (2011). EVALUATING BEHAVIOUR OF SELF AND OTHERS IN FRONTOTEMPORAL LOBAR DEGENERATION. J NEUROL NEUROSUR PS, 82(9), - . doi:10.1136/jnnp-2011-300645.3
    • Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, van Swieten JC, Seelaar H, Dopper EGP, Onyike CU, Hillis AE, Josephs KA, Boeve BF, Kertesz A, Seeley WW, Rankin KP, Johnson JK, Gorno-Tempini ML, Rosen H, Prioleau-Latham CE, Lee A, Kipps CM, Lillo P, Piguet O, Rohrer JD, Rossor MN, Warren JD, Fox NC, Galasko D, Salmon DP, Black SE, Mesulam M, Weintraub S, Dickerson BC, Diehl-Schmid J, Pasquier F, Deramecourt V, Lebert F, Pijnenburg Y, Chow TW, Manes F, Grafman J, Cappa SF, Freedman M, Grossman M, Miller BL (2011). Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. BRAIN, 134, 2456 - 2477. doi:10.1093/brain/awr179
    • Schott JM, Warren JD, Barkhof F, Rossor MN, Fox NC (2011). RATIONAL IMAGING Suspected early dementia. BRIT MED J, 343, - . doi:10.1136/bmj.d5568
    • Leung KK, Ridgway GR, Ourselin S, Fox NC (2011). Consistent multi-time-point brain atrophy estimation from the boundary shift integral. NeuroImage, (0), - . doi:10.1016/j.neuroimage.2011.10.068
    • Hampel H, Wilcock G, Andrieu S, Aisen P, Blennow K, Broich K, Carrillo M, Fox NC, Frisoni GB, Isaac M, Lovestone S, Nordberg A, Prvulovic D, Sampaio C, Scheltens P, Weiner M, Winblad B, Coley N, Vellas B, Grp OTF (2011). Biomarkers for Alzheimer's disease therapeutic trials. PROGRESS IN NEUROBIOLOGY, 95(4), 579 - 593. doi:10.1016/j.pneurobio.2010.11.005
    • Knight WD, Kim LG, Douiri A, Frost C, Rossor MN, Fox NC (2011). Acceleration of cortical thinning in familial Alzheimer's disease.. Neurobiol Aging, 32(10), 1765 - 1773. doi:10.1016/j.neurobiolaging.2009.11.013

    2010

    • Evans MC, Barnes J, Nielsen C, Kim LG, Clegg SL, Blair M, Leung KK, Douiri A, Boyes RG, Ourselin S, Fox NC, Alzheimer's Disease Neuroimaging Initiative (2010). Volume changes in Alzheimer's disease and mild cognitive impairment: cognitive associations.. Eur Radiol, 20(3), 674 - 682. doi:10.1007/s00330-009-1581-5
    • Schott JM, Bartlett JW, Fox NC, Barnes J, Alzheimer's Disease Neuroimaging Initiative Investigators (2010). Increased brain atrophy rates in cognitively normal older adults with low cerebrospinal fluid Aβ1-42.. Ann Neurol, 68(6), 825 - 834. doi:10.1002/ana.22315
    • Henley SM, Ridgway GR, Scahill RI, Klöppel S, Tabrizi SJ, Fox NC, Kassubek J, EHDN Imaging Working Group (2010). Pitfalls in the use of voxel-based morphometry as a biomarker: examples from huntington disease.. AJNR Am J Neuroradiol, 31(4), 711 - 719. doi:10.3174/ajnr.A1939
    • Clarkson MJ, Malone IB, Modat M, Leung KK, Ryan N, Alexander DC, Fox NC, Ourselin S (2010). A Framework for Using Diffusion Weighted Imaging to Improve Cortical Parcellation.
    • Petzold A, Chapman MD, Schraen S, Verwey NA, Pasquier F, Bombois S, Brettschneider J, Fox N, van Arnim CA, Teunissen C, Pijnenburg Y, Riepe W, Otto M, Tumani H, Scheltens P, Buee L, Rossor MN (2010). An unbiased, staged, multi-center, validation strategy for Alzheimer's disease CSF tau levels. Experimental Neurology, 223, 432 - 438.
    • Jones L, Holmans PA, Hamshere ML, Harold D, Moskvina V, Ivanov D, Pocklington A, Abraham R, Hollingworth P, Sims R, Gerrish A, Pahwa JS, Jones N, Stretton A, Morgan AR, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Morgan K, Brown KS, Passmore PA, Craig D, McGuinness B, Todd S, Holmes C, Mann D, Smith AD, Love S, Kehoe PG, Mead S, Fox N, Rossor M, Collinge J, Maier W, Jessen F, Schürmann B, Heun R, Kölsch H, van den Bussche H, Heuser I, Peters O, Kornhuber J, Wiltfang J, Dichgans M, Frölich L, Hampel H, Hüll M, Rujescu D, Goate AM, Kauwe JS, Cruchaga C, Nowotny P, Morris JC, Mayo K, Livingston G, Bass NJ, Gurling H, McQuillin A, Gwilliam R, Deloukas P, Al-Chalabi A, Shaw CE, Singleton AB, Guerreiro R, Mühleisen TW, Nöthen MM, Moebus S, Jöckel KH, Klopp N, Wichmann HE, Rüther E, Carrasquillo MM, Pankratz VS, Younkin SG, Hardy J, O'Donovan MC, Owen MJ, Williams J (2010). Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease.. PLoS One, 5(11), e13950 - . doi:10.1371/journal.pone.0013950
    • Guerreiro RJ, Beck J, Gibbs JR, Santana I, Rossor MN, Schott JM, Nalls MA, Ribeiro H, Santiago B, Fox NC, Oliveira C, Collinge J, Mead S, Singleton A, Hardy J (2010). Genetic variability in CLU and its association with Alzheimer's disease.. PLoS One, 5(3), e9510 - . doi:10.1371/journal.pone.0009510
    • Leung KK, Shen K-K, Barnes J, Ridgway GR, Clarkson MJ, Fripp J, Salvado O, Meriaudeau F, Fox NC, Bourgeat P, Ourselin S (2010). Increasing Power to Predict Mild Cognitive Impairment Conversion to Alzheimer’s Disease Using Hippocampal Atrophy Rate and Statistical Shape Models.
    • Archer HA, Kennedy J, Barnes J, Pepple T, Boyes R, Randlesome K, Clegg S, Leung KK, Ourselin S, Frost C, Rossor MN, Fox NC (2010). Memory complaints and increased rates of brain atrophy: risk factors for mild cognitive impairment and Alzheimer's disease.. Int J Geriatr Psychiatry, 25(11), 1119 - 1126. doi:10.1002/gps.2440
    • Modat M, Vercauteren T, Ridgway GR, Hawkes DJ, Fox NC, Ourselin S (2010). Diffeomorphic demons using normalized mutual information, evaluation on multimodal brain MR images.
    • Modat M, Taylor Z, Ridgway G, Barnes J, Wild E, Hawkes DJ, Fox N, Ourselin S (2010). Nonlinear Elastic Spline Registration: Evaluation with Longitudinal Huntington’s Disease Data. doi:10.1007/978-3-642-14366-3_12
    • Modat M, Ridgway GR, Hawkes DJ, Fox NC, Ourselin S (2010). Nonrigid registration with differential bias correction using normalised mutual information. doi:10.1109/ISBI.2010.5490337
    • Lehmann M, Rohrer JD, Clarkson MJ, Ridgway GR, Scahill RI, Modat M, Warren JD, Ourselin S, Barnes J, Rossor MN, Fox NC (2010). Reduced Cortical Thickness in the Posterior Cingulate Gyrus is Characteristic of Both Typical and Atypical Alzheimer's Disease. J ALZHEIMERS DIS, 20(2), 587 - 598. doi:10.3233/JAD-2010-1401
    • Rohrer JD, Ridgway GR, Modat M, Ourselin S, Mead S, Fox NC, Rossor MN, Warren JD (2010). Distinct profiles of brain atrophy in frontotemporal lobar degeneration caused by progranulin and tau mutations.. Neuroimage, 53(3), 1070 - 1076. doi:10.1016/j.neuroimage.2009.12.088
    • Lehmann M, Douiri A, Kim LG, Modat M, Chan D, Ourselin S, Barnes J, Fox NC (2010). Atrophy patterns in Alzheimer's disease and semantic dementia: a comparison of FreeSurfer and manual volumetric measurements.. Neuroimage, 49(3), 2264 - 2274. doi:10.1016/j.neuroimage.2009.10.056
    • Frisoni GB, Fox NC, Jack CR, Scheltens P, Thompson PM (2010). The clinical use of structural MRI in Alzheimer disease. NAT REV NEUROL, 6(2), 67 - 77. doi:10.1038/nrneurol.2009.215
    • Hobbs NZ, Barnes J, Frost C, Henley SM, Wild EJ, Macdonald K, Barker RA, Scahill RI, Fox NC, Tabrizi SJ (2010). Onset and progression of pathologic atrophy in Huntington disease: a longitudinal MR imaging study.. AJNR Am J Neuroradiol, 31(6), 1036 - 1041. doi:10.3174/ajnr.A2018
    • Hyare H, Wroe S, Siddique D, Webb T, Fox NC, Stevens J, Collinge J, Yousry T, Thornton JS (2010). Brain-water diffusion coefficients reflect the severity of inherited prion disease. NEUROLOGY, 74(8), 658 - 665.
    • Gordon E, Rohrer JD, Kim LG, Omar R, Rossor MN, Fox NC, Warren JD (2010). Measuring disease progression in frontotemporal lobar degeneration: a clinical and MRI study.. Neurology, 74(8), 666 - 673. doi:10.1212/WNL.0b013e3181d1a879
    • Barnes J, Mitchell LA, Kennedy J, Bastos-Leite AJ, Barker S, Lehmann M, Nordstrom RC, Frost C, Smith JR, Garde E, Rossor MN, Fox NC (2010). Does registration of serial MRI improve diagnosis of dementia?. Neuroradiology, 52(11), 987 - 995. doi:10.1007/s00234-010-0665-x
    • Rinne JO, Brooks DJ, Rossor MN, Fox NC, Bullock R, Klunk WE, Mathis CA, Blennow K, Barakos J, Okello AA, de Llano SRM, Liu E, Koller M, Gregg KM, Schenk D, Black R, Grundman M (2010). C-11-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study. LANCET NEUROL, 9(4), 363 - 372. doi:10.1016/S1474-4422(10)70043-0
    • Leung KK, Clarkson MJ, Bartlett JW, Clegg S, Jack CR, Weiner MW, Fox NC, Ourselin S, the ADNI (2010). Robust atrophy rate measurement in Alzheimer's disease using multi-site serial MRI: Tissue-specific intensity normalization and parameter selection. Neuroimage, 50(2), 516 - 523. doi:10.1016/j.neuroimage.2009.12.059
    • Leung KK, Clarkson MJ, Bartlett JW, Clegg S, Jack CR, Weiner MW, Fox NC, Ourselin S (2010). Robust atrophy rate measurement in Alzheimer's disease using multi-site serial MRI: Tissue-specific intensity normalization and parameter selection.. Neuroimage, 50(2), 516 - 523. doi:10.1016/j.neuroimage.2009.12.059
    • Revesz T, Lashley T, Ahmed Z, Rohrer J, Warren J, Al-Saraj S, Fox N, Braendgaard H, Rossor M, Lees A, Holton J (2010). The Spectrum of FUS-Positive Pathology in Frontotemporal Lobar Degenerations.
    • Jack CR, Bernstein MA, Borowski BJ, Gunter JL, Fox NC, Thompson PM, Schuff N, Krueger G, Killiany RJ, DeCarli CS, Dale AM, Carmichael OW, Tosun D, Weiner MW, Alzheimer's Dis Neuroimaging Initi (2010). Update on the Magnetic Resonance Imaging core of the Alzheimer's Disease Neuroimaging Initiative. ALZHEIMERS DEMENT, 6(3), 212 - 220. doi:10.1016/j.jalz.2010.03.004
    • Wild EJ, Henley SMD, Hobbs NZ, Frost C, MacManus DG, Barker RA, Fox NC, Tabrizi SJ (2010). Rate and acceleration of whole-brain atrophy in premanifest and early Huntington’s disease. Movement Disorders, 25(7), - . doi:10.1002/mds.22969
    • Leung KK, Barnes J, Ridgway GR, Bartlett JW, Clarkson MJ, Macdonald K, Schuff N, Fox NC, Ourselin S (2010). Automated cross-sectional and longitudinal hippocampal volume measurement in mild cognitive impairment and Alzheimer's disease. NeuroImage, 51(4), 1345 - 1359. doi:10.1016/j.neuroimage.2010.03.018
    • Schott JM, Bartlett JW, Barnes J, Leung KK, Ourselin S, Fox NC (2010). Reduced sample sizes for atrophy outcomes in Alzheimer's disease trials: baseline adjustment. Neurobiol Aging, 31(8), 1452 - 1462.e2.
    • Rossor MN, Fox NC, Mummery CJ, Schott JM, Warren JD (2010). The diagnosis of young-onset dementia.. Lancet Neurol, 9(8), 793 - 806. doi:10.1016/S1474-4422(10)70159-9
    • Schott JM, Frost C, MacManus DG, Ibrahim F, Waldman AD, Fox NC (2010). Short echo time proton magnetic resonance spectroscopy in Alzheimer's disease: a longitudinal multiple time point study.. Brain, 133(11), 3315 - 3322. doi:10.1093/brain/awq208
    • Ryan NS, Malone I, Lehmann M, Crutch S, Ourselin S, Ciccarelli O, Fox NC (2010). Patterns of white matter tract degeneration and grey matter loss in posterior cortical atrophy and typical amnestic presentations of Alzheimer's disease.
    • Massey L, Paviour DC, Fox NC, Micallef C, Burn DJ, Holton JL, Lees AJ, Jager HR, Revesz T, O'Sullivan SS (2010). BLINDED ANALYSIS OF CONVENTIONAL MRI IN A COHORT OF PATHOLOGICALLY CONFIRMED PARKINSONIAN ILLNESSES. doi:10.1136/jnnp.2010.226340.161
    • Lahiri N, Tabrizi SJ, Kennard C, Durr A, Leavitt BR, Fox N, Roos RA (2010). POMD07 Quantitative assessment of biological and clinical manifestations of Huntington's disease before and after diagnosis--the TRACK-HD study.. J Neurol Neurosurg Psychiatry, 81(11), e59 - . doi:10.1136/jnnp.2010.226340.167
    • Dubois B, Feldman HH, Jacova C, Cummings JL, DeKosky ST, Barberger-Gateau P, Delacourte A, Frisoni G, Fox NC, Galasko D, Gauthier S, Hampel H, Jicha GA, Meguro K, O'Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Sarazin M, de Souza LC, Stern Y, Visser PJ, Scheltens P (2010). Revising the definition of Alzheimer's disease: a new lexicon. LANCET NEUROL, 9(11), 1118 - 1127. doi:10.1016/S1474-4422(10)70223-4
    • Barnes J, Ridgway GR, Bartlett J, Henley SM, Lehmann M, Hobbs N, Clarkson MJ, MacManus DG, Ourselin S, Fox NC (2010). Head size, age and gender adjustment in MRI studies: a necessary nuisance?. Neuroimage, 53(4), 1244 - 1255. doi:10.1016/j.neuroimage.2010.06.025
    • Modat M, Ridgway GR, Taylor ZA, Lehmann M, Barnes J, Hawkes DJ, Fox NC, Ourselin S (2010). Fast free-form deformation using graphics processing units.. Comput Methods Programs Biomed, 98(3), 278 - 284. doi:10.1016/j.cmpb.2009.09.002

    2009

    • Rossor M, Collinge J, Fox N, Howard R, Mallucci G, Mummery C, Warren J (2009). Cognitive impairment and dementia. In Clarke C, Howard R, Rossor M, Shorvon S (Ed.), Neurology: a Queen Square textbook (pp. 245 - 288). : Wiley-Blackwell.
    • Salloway S, Sperling R, Gilman S, Fox NC, Blennow K, Raskind M, Sabbagh M, Honig LS, Doody R, van Dyck CH, Mulnard R, Barakos J, Gregg KM, Liu E, Lieberburg I, Schenk D, Black R, Grundman M, Bapineuzumab 201 Clin Trial Invest (2009). A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease. NEUROLOGY, 73(24), 2061 - 2070. doi:10.1212/WNL.0b013e3181c67808
    • Ridgway GR, Omar R, Ourselin S, Hill DLG, Warren JD, Fox NC (2009). Issues with threshold masking in voxel-based morphometry of atrophied brains.. NeuroImage, 44(1), 99 - 111. doi:10.1016/j.neuroimage.2008.08.045
    • Okello A, Edison P, Archer HA, Turkheimer FE, Kennedy J, Bullock R, Walker Z, Kennedy A, Fox N, Rossor M, Brooks DJ (2009). Microglial activation and amyloid deposition in mild cognitive impairment: a PET study. Neurology, 72(1), 56 - 62. doi:10.1212/01.wnl.0000338622.27876.0d
    • Wild EJ, Fox NC (2009). Serial volumetric MRI in Parkinsonian disorders.. Mov Disord, 24 Suppl 2, S691 - S698. doi:10.1002/mds.22500
    • Henley SMD, Wild EJ, Hobbs NZ, Scahill RI, Ridgway GR, MacManus DG, Barker RA, Fox NC, Tabrizi SJ (2009). Relationship between CAG repeat length and brain volume in premanifest and early Huntington's disease.. Journal of Neurology, 256(2), 203 - 212. doi:10.1007/s00415-009-0052-x
    • Henneman WJP, Sluimer JD, Barnes J, van der Flier WM, Sluimer IC, Fox NC, Scheltens P, Vrenken H, Barkhof F (2009). Hippocampal atrophy rates in Alzheimer disease: added value over whole brain volume measures. Neurology, 72(11), 999 - 1007. doi:10.1212/01.wnl.0000344568.09360.31
    • Rohrer JD, Ahsan RL, Isaacs AM, Nielsen JE, Ostergaard L, Scahill R, Warren JD, Rossor MN, Fox NC, Johannsen P (2009). Presymptomatic generalized brain atrophy in frontotemporal dementia caused by CHMP2B mutation. Dementia and Geriatric Cognitive Disorders, 27(2), 182 - 186. doi:10.1159/000200466
    • Kloppel S, Stonnington CM, Chu C, Draganski B, Scahill RI, Rohrer JD, Fox NC, Ashburner J, Frackowiak RSJ (2009). A plea for confidence intervals and consideration of generalizability in diagnostic studies. BRAIN, 132, - . doi:10.1093/brain/awn091
    • Omar R, Sampson EL, Loy CT, Mummery CJ, Fox NC, Rossor MN, Warren JD (2009). Delusions in frontotemporal lobar degeneration. Journal of Neurology, 256(4), 600 - 607. doi:10.1007/s00415-009-0128-7
    • Vellas B, Black R, Thal LJ, Fox NC, Daniels M, McLennan G, Tompkins C, Leibman C, Pomfret M, Grundman M (2009). Long-term follow-up of patients immunized with AN1792: reduced functional decline in antibody responders. Current Alzheimer Research, 6(2), 144 - 151. doi:10.2174/156720509787602852
    • Fox NC, Kennedy J (2009). Structural imaging markers for therapeutic trials in Alzheimer's disease.. J Nutr Health Aging, 13(4), 350 - 352.
    • Henley SMD, Wild EJ, Hobbs NZ, Frost C, MacManus DG, Barker RA, Fox NC, Tabrizi SJ (2009). Whole-brain atrophy as a measure of progression in premanifest and early Huntington's disease.. Movement Disorders, 24(6), 932 - 936. doi:10.1002/mds.22485
    • Ryan NS, Fox NC (2009). Alzheimer disease: Visual rating of atrophy aids diagnostic accuracy. Nature Reviews Neurology, 5(5), 243 - 244. doi:10.1038/nrneurol.2009.52
    • Rohrer JD, Warren JD, Modat M, Ridgway GR, Douiri A, Rossor MN, Ourselin S, Fox NC (2009). Patterns of cortical thinning in the language variants of frontotemporal lobar degeneration. Neurology, 72(18), 1562 - 1569. doi:10.1212/WNL.0b013e3181a4124e
    • Chan D, Anderson V, Pijnenburg Y, Whitwell J, Barnes J, Scahill R, Stevens JM, Barkhof F, Scheltens P, Rossor MN, Fox NC (2009). The clinical profile of right temporal lobe atrophy. Brain, 132(5), 1287 - 1298. doi:10.1093/brain/awp037
    • Barnes J, Ourselin S, Fox NC (2009). Clinical application of measurement of hippocampal atrophy in degenerative dementias. Hippocampus, 19(6), 510 - 516. doi:10.1002/hipo.20617
    • Tabrizi SJ, Langbehn DR, Leavitt BR, Roos RAC, Durr A, Craufurd D, Kennard C, Hicks SL, Fox NC, Scahill RI, Borowsky B, Tobin AJ, Rosas HD, Johnson H, Reilmann R, Landwehrmeyer B, Stout JCATT-HI (2009). Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. The Lancet Neurology, 8(9), 791 - 801. doi:10.1016/S1474-4422(09)70170-X
    • Okello A, Koivunen J, Edison P, Archer HA, Turkheimer FE, Nagren K, Bullock R, Walker Z, Kennedy A, Fox NC, Rossor MN, Rinne JO, Brooks DJ (2009). Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study.. Neurology, 73(10), 754 - 760. doi:10.1212/WNL.0b013e3181b23564
    • Cardoso MJ, Clarkson MJ, Ridgway GR, Modat M, Fox NC, Ourselin S (2009). Improved Maximum a Posteriori Cortical Segmentation by Iterative Relaxation of Priors.
    • Gutiérrez-Galve L, Lehmann M, Hobbs NZ, Clarkson MJ, Ridgway GR, Crutch S, Ourselin S, Schott JM, Fox NC, Barnes J (2009). Patterns of cortical thickness according to APOE genotype in Alzheimer's disease.. Dement Geriatr Cogn Disord, 28(5), 476 - 485. doi:10.1159/000258100
    • Henneman WJP, Vrenken H, Barnes J, Sluimer IC, Verwey NA, Blankenstein MA, Klein M, Fox NC, Scheltens P, Barkhof F, van der Flier WM (2009). Baseline CSF p-tau levels independently predict progression of hippocampal atrophy in Alzheimer disease. NEUROLOGY, 73(12), 935 - 940. doi:10.1212/WNL.0b013e3181b879ac
    • Hobbs NZ, Henley SMD, Wild EJ, Leung KK, Frost C, Barker RA, Scahill RI, Barnes J, Tabrizi SJ, Fox NC (2009). Automated quantification of caudate atrophy by local registration of serial MRI: evaluation and application in Huntington's disease. Neuroimage, 47(4), 1659 - 1665. doi:10.1016/j.neuroimage.2009.06.003
    • Clarkson MJ, Ourselin S, Nielsen C, Leung KK, Barnes J, Whitwell JL, Gunter JL, Hill DLG, Weiner MW, Jack CR, Fox NC, The ADNI (2009). Comparison of phantom and registration scaling corrections using the ADNI cohort. NeuroImage, 47(4), 1506 - 1513. doi:10.1016/j.neuroimage.2009.05.045
    • Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Williams A, Jones N, Thomas C, Stretton A, Morgan AR, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Morgan K, Brown KS, Passmore PA, Craig D, McGuinness B, Todd S, Holmes C, Mann D, Smith AD, Love S, Kehoe PG, Hardy J, Mead S, Fox N, Rossor M, Collinge J, Maier W, Jessen F, Schürmann B, Heun R, van den Bussche H, Heuser I, Kornhuber J, Wiltfang J, Dichgans M, Frölich L, Hampel H, Hüll M, Rujescu D, Goate AM, Kauwe JS, Cruchaga C, Nowotny P, Morris JC, Mayo K, Sleegers K, Bettens K, Engelborghs S, De Deyn PP, Van Broeckhoven C, Livingston G, Bass NJ, Gurling H, McQuillin A, Gwilliam R, Deloukas P, Al-Chalabi A, Shaw CE, Tsolaki M, Singleton AB, Guerreiro R, Mühleisen TW, Nöthen MM, Moebus S, Jöckel KH, Klopp N, Wichmann HE, Carrasquillo MM, Pankratz VS, Younkin SG, Holmans PA, O'Donovan M, Owen MJ, Williams J (2009). Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease.. Nat Genet, 41(10), 1088 - 1093. doi:10.1038/ng.440
    • Ryan NS, Fox NC (2009). Imaging biomarkers in Alzheimer's disease.. Ann N Y Acad Sci, 1180, 20 - 27. doi:10.1111/j.1749-6632.2009.05062.x
    • Knight WD, Ahsan RL, Jackson J, Cipolotti L, Warrington EK, Fox NC, Rossor MN (2009). Pure progressive amnesia and the APPV717G mutation.. Alzheimer Dis Assoc Disord, 23(4), 410 - 414.
    • Ryan N, Rohrer J, Warrington E, Galton M, Fox N, Rossor M, Warren J (2009). Selective preservation of visual motion perception in posterior cortical degeneration.
    • Barnes J, Bartlett JW, van de Pol LA, Loy CT, Scahill RI, Frost C, Thompson P, Fox NC (2009). A meta-analysis of hippocampal atrophy rates in Alzheimer's disease. Neurobiology of Aging, 30(11), 1711 - 1723. doi:10.1016/j.neurobiolaging.2008.01.010
    • Rohrer JD, Guerreiro R, Vandrovcova J, Uphill J, Reiman D, Beck J, Isaacs AM, Authier A, Ferrari R, Fox NC, Mackenzie IRA, Warren JD, de Silva R, Holton J, Revesz T, Hardy J, Mead S, Rossor MN (2009). The heritability and genetics of frontotemporal lobar degeneration. Neurology, 73(18), 1451 - 1456. doi:10.1212/WNL.0b013e3181bf997a
    • Sluimer JD, van der Flier WM, Karas GB, van Schijndel R, Barnes J, Boyes RG, Cover KS, Olabarriaga SD, Fox NC, Scheltens P, Vrenken H, Barkhof F (2009). Accelerating regional atrophy rates in the progression from normal aging to Alzheimer's disease. EUR RADIOL, 19(12), 2826 - 2833. doi:10.1007/s00330-009-1512-5
    • Lloyd SE, Rossor M, Fox N, Mead S, Collinge J (2009). HECTD2, a candidate susceptibility gene for Alzheimer's disease on 10q.. BMC Med Genet, 10, 90 - . doi:10.1186/1471-2350-10-90

    2008

    • Tofts PS, Jackson JS, Tozer DJ, Cercignani M, Keir G, MacManus DG, Ridgway GR, Ridha BH, Schmierer K, Siddique D, Thornton JS, Wroe SJ, Fox NC (2008). Imaging cadavers: Cold FLAIR and noninvasive brain thermometry using CSF diffusion. Magnetic Resonance in Medicine, 59(1), 190 - 195. doi:10.1002/mrm.21456
    • Edison P, Archer HA, Gerhard A, Hinz R, Pavese N, Turkheimer FE, Hammers A, Tai YF, Fox N, Kennedy A, Rossor M, Brooks DJ (2008). Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study. Neurobiology of Disease, 32(3), 412 - 419. doi:10.1016/j.nbd.2008.08.001
    • Boyes RG, Gunter JL, Frost C, Janke AL, Yeatman T, Hill DLG, Bernstein MA, Thompson PM, Weiner MW, Schuff N, Alexander GE, Killiany RJ, Decarli C, Jack CR, Fox NC (2008). Intensity non-uniformity correction using N3 on 3-T scanners with multichannel phased array coils. NeuroImage, 39(4), 1752 - 1762. doi:10.1016/j.neuroimage.2007.10.026
    • Knight WD, Fox NC, Rossor MN, Warren JD (2008). The cultural context of visual hallucinations. Postgraduate Medical Journal, 84(988), 103 - 105. doi:10.1136/pgmj.2007.063727
    • Beck J, Rohrer JD, Campbell T, Isaacs A, Morrison KE, Goodall EF, Warrington EK, Stevens J, Revesz T, Holton J, Al-Sarraj S, King A, Scahill R, Warren JD, Fox NC, Rossor MN, Collinge J, Mead S (2008). A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK series. Brain, 131(3), 706 - 720. doi:10.1093/brain/awm320
    • Kloppel S, Stonnington CM, Chu C, Draganski B, Scahill RI, Rohrer JD, Fox NC, Jack CR, Ashburner J, Frackowiak RS (2008). Automatic classification of MR scans in Alzheimer's disease. Brain, 131(3), 681 - 689. doi:10.1093/brain/awm319
    • Okello A, Edison P, Archer H, Walker Z, Fox N, Kennedy A, Rossor M, Brooks DJ (2008). In vivo imaging of amyloid deposition and neuroinflammation in mild cognitive impairment with 11C-PIB and 11C-PK11195 pet.
    • Rohrer JD, Warren JD, Omar R, Mead S, Beck J, Revesz T, Holton J, Stevens JM, Al-Sarraj S, Pickering-Brown SM, Hardy J, Fox NC, Collinge J, Warrington EK, Rossor MN (2008). Parietal lobe deficits in frontotemporal lobar degeneration caused by a mutation in the progranulin gene. Archives of Neurology, 65(4), 506 - 513. doi:10.1001/archneur.65.4.506
    • Jack CR, Bernstein MA, Fox NC, Thompson P, Alexander G, Harvey D, Borowski B, Britson PJ, Whitwell JL, Ward C, Dale AM, Felmlee JP, Gunter JL, Hill DLG, Killiany R, Schuff N, Fox-Bosetti S, Lin C, Studholme C, DeCarli CS, Krueger G, Ward HA, Metzger GJ, Scott KT, Mallozzi R, Blezek D, Levy J, Debbins JP, Fleisher AS, Albert M, Green R, Bartzokis G, Glover G, Mugler J, Weiner MW, ADNI Study (2008). The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods. J MAGN RESON IMAGING, 27(4), 685 - 691. doi:10.1002/jmri.21049
    • Ridha BH, Anderson VM, Barnes J, Boyes RG, Price SL, Rossor MN, Whitwell JL, Fox NC, Jenkins L, Black RS, Grundman M (2008). Volumetric MRI and cognitive measures in Alzheimer disease - Comparison of markers of progression. Journal of Neurology, , - . doi:10.1007/s00415-008-0750-9
    • Ridha BH, Anderson VM, Barnes J, Boyes RG, Price SL, Rossor MN, Whitwell JL, Jenkins L, Black RS, Grundman M, Fox NC (2008). Volumetric MRI and cognitive measures in Alzheimer disease : Comparison of markers of progression. Journal of Neurology, 255(4), 567 - 574. doi:10.1007/s00415-008-0750-9
    • Hua X, Leow AD, Lee S, Klunder AD, Toga AW, Lepore N, Chou YY, Brun C, Chiang MC, Barysheva M, Jack CR, Jr B, M A B, P J W, C P W, J L B, B F, A S F, N C B, R G B, J H, D K, J S, N B, L A, G E W, M W T, P M ADNI (2008). 3D characterization of brain atrophy in Alzheimer's disease and mild cognitive impairment using tensor-based morphometry. NeuroImage, 41(1), 19 - 34. doi:10.1016/j.neuroimage.2008.02.010
    • Barnes J, Foster J, Boyes RG, Pepple T, Moore EK, Schott JM, Frost C, Scahill RI, Fox NC (2008). A comparison of methods for the automated calculation of volumes and atrophy rates in the hippocampus. NeuroImage, 40(4), 1655 - 1671. doi:10.1016/j.neuroimage.2008.01.012
    • Karas G, Sluimer J, Goekoop R, van der Flier W, Rombouts SARB, Vrenken H, Scheltens P, Fox N, Barkhof F (2008). Amnestic mild cognitive impairment: structural MR imaging findings predictive of conversion to Alzheimer disease. American Journal of Neuroradiology, 29(5), 944 - 949. doi:10.3174/ajnr.A0949
    • Vellas B, Andrieu S, Sampaio C, Coley N, Wilcock G (2008). Endpoints for trials in Alzheimer's disease: a European task force consensus.. The Lancet Neurology, 7(5), 436 - 450. doi:10.1016/S1474-4422(08)70087-5
    • Schott JM, Crutch SJ, Frost C, Warrington EK, Rossor MN, Fox NC (2008). Neuropsychological correlates of whole brain atrophy in Alzheimer's disease. Neuropsychologia, 46(6), 1732 - 1737. doi:10.1016/j.neuropsychologia.2008.02.015
    • Ridgway GR, Henley SMD, Rohrer JD, Scahill RI, Warren JD, Fox NC (2008). Ten simple rules for reporting voxel-based morphometry studies. NeuroImage, 40(4), 1429 - 1435. doi:10.1016/j.neuroimage.2008.01.003
    • Sluimer JD, Vrenken H, Blankenstein MA, Fox NC, Scheltens P, Barkhof F, van der Flier WM (2008). Whole-brain atrophy rate in Alzheimer disease - Identifying fast progressors. Neurology, 70(19 (part 2)), 1836 - 1841. doi:10.1212/01.wnl.0000311446.61861.e3
    • Henley SMD, Wild EJ, Hobbs NZ, Warren JD, Frost C, Scahill RI, Ridgway GR, MacManus DG, Barker RA, Fox NC, Tabrizi SJ (2008). Defective emotion recognition in early HD is neuropsychologically and anatomically generic. Neuropsychologia, 46(8), 2152 - 2160. doi:10.1016/j.neuropsychologia.2008.02.025
    • Camara O, Schnabel JA, Ridgway GR, Crum WR, Douiri A, Scahill RI, Hill DLG, Fox NC (2008). Accuracy assessment of global and local atrophy measurement techniques with realistic simulated longitudinal Alzheimer's disease images. NeuroImage, 42(2), 696 - 709. doi:10.1016/j.neuroimage.2008.04.259
    • Barnes J, Scahill RI, Frost C, Schott JM, Rossor MN, Fox NC (2008). Increased hippocampal atrophy rates in AD over 6 months using serial MR imaging.. Neurobiol Aging, 29(8), 1199 - 1203. doi:10.1016/j.neurobiolaging.2007.02.011
    • Rohrer JD, Warren JD, Barnes J, Mead S, Beck J, Pepple T, Boyes R, Omar R, Collinge J, Stevens JM, Warrington EK, Rossor MN, Fox NC (2008). Mapping the progression of progranulin-associated frontotemporal lobar degeneration. Nature Clinical Practice Neurology, 4(8), 455 - 460. doi:10.1038/ncpneuro0869
    • Frost C, Kenward MG, Fox NC (2008). Optimizing the design of clinical trials where the outcome is a rate. Can estimating a baseline rate in a run-in period increase efficiency?. Statistics in Medicine, 27(19), 3717 - 3731. doi:10.1002/sim.3280
    • Sluimer JD, van der Flier WM, Karas GB, Fox NC, Scheltens P, Barkhof F, Vrenken H (2008). Whole-brain atrophy rate and cognitive decline: longitudinal MR study of memory clinic patients. Radiology, 248(2), 590 - 598. doi:10.1148/radiol.2482070938
    • Rohrer JD, McNaught E, Foster J, Clegg SL, Barnes J, Omar R, Warrington EK, Rossor MN, Warren JD, Fox NC (2008). Tracking progression in frontotemporal lobar degeneration. Serial MRI in semantic dementia. Neurology, 71(18), 1445 - 1451. doi:10.1212/01.wnl.0000327889.13734.cd
    • Kloppel S, Stonnington CM, Barnes J, Chen F, Chu C, Good CD, Mader I, Mitchell LA, Patel AC, Roberts CC, Fox NC, Jack CRJ, Ashburner J, Frackowiak RS (2008). Accuracy of dementia diagnosis: a direct comparison between radiologists and a computerized method. Brain, 131(11), 2969 - 2974. doi:10.1093/brain/awn239
    • Rohrer JD, Knight WD, Warren JE, Fox NC, Rossor MN, Warren JD (2008). Word-finding difficulty: a clinical analysis of the progressive aphasias. Brain, 131(1), 8 - 38. doi:10.1093/brain/awm251

    2007

    • Camara O, Scahill RI, Schnabel JA, Crum WR, Ridgway GR, Hill DL, Fox NC (2007). Accuracy assessment of global and local atrophy measurement techniques with realistic simulated longitudinal data..
    • Barnes J, Godbolt AK, Frost C, Boyes RG, Jones BF, Scahill RI, Rossor MN, Fox NC (2007). Atrophy rates of the cingulate gyrus and hippocampus in AD and FTLD. Neurobiology of Aging, 28(1), 20 - 28.
    • Anderson VM, Fernando KTM, Davies GR, Rashid W, Frost C, Fox NC, Miller DH (2007). Cerebral atrophy measurement in clinically isolated syndromes and relapsing remitting multiple sclerosis: A comparison of registration-based methods. Journal of Neuroimaging, 17(1), 61 - 68. doi:10.1111/j.1552-6569.2006.00081.x
    • Edison P, Okello A, Archer H, Hinz R, Fox N, Kennedy A, Rossor M, Brooks DJ (2007). Amyloid deposition and cerebral glucose metabolism in Alzheimer's disease: A longitudinal 11C-PIB and 18F-FDG PET study.
    • Okello A, Edison P, Archer H, Hinz R, Fox N, Kennedy A, Rossor M, Brooks DJ (2007). Amyloid deposition and cerebral glucose metabolism in mild cognitive impairment: A longitudinal 11C-PIB and 18F-FDG PET study.
    • Edison P, Archer HA, Hinz R, Hammers A, Pavese N, Tai YF, Hotton G, Cutler D, Fox N, Kennedy A, Rossor M, Brooks DJ (2007). Amyloid, hypometabolism, and cognition in Alzheimer disease. An [11C]PIB and [18F]FDG PET study. Neurology, 68(7), 501 - 508. doi:10.1212/01.wnl.0000244749.20056.d4
    • van de Pol LA, Barnes J, Scahill RI, Frost C, Lewis EB, Boyes RG, van Schijndel RA, Scheltens P, Fox NC, Barkhof F (2007). Improved reliability of hippocampal atrophy rate measurement in mild cognitive impairment using fluid registration. NeuroImage, 34(3), 1036 - 1041. doi:10.1016/j.neuroimage.2006.10.033
    • Edison P, Archer H, Hinz R, Fox N, Kennedy A, Rossor M, Brooks DJ (2007). Relationship between the distribution of microglial activation and amyloid deposition in Alzheimer's disease: An 11C-PK11195 and 11C-PIB PET study.
    • Whitwell JL, Sampson EL, Loy CT, Warren JE, Rossor MN, Fox NC, Warren JD (2007). VBM signatures of abnormal eating behaviours in frontotemporal lobar degeneration. NeuroImage, 35(1), 207 - 213. doi:10.1016/j.neuroimage.2006.12.006
    • Paviour DC, Price SL, Lees AJ, Fox NC (2007). MRI derived brain atrophy in PSP and MSA-P. Determining sample size to detect treatment effects. Journal of Neurology, 254(4), 478 - 481. doi:10.1007/s00415-006-0396-4
    • Archer HA, McFarlane F, Frost C, Cutler D, Fox NC, Rossor MN (2007). Symptoms of memory loss as predictors of cognitive impairment?: the use and reliability of memory ratings in a clinic population. Alzheimer Disease and Associated Disorders, 21(2), 101 - 106.
    • Ridha BH, Symms MR, Tozer DJ, Stockton KC, Frost C, Siddique MM, Lewis EB, MacManus DG, Boulby PA, Barker GJ, Rossor MN, Fox NC, Tofts PS (2007). Magnetization transfer ratio in Alzheimer disease: Comparison with volumetric measurements. American Journal of Neuroradiology, 28(5), 965 - 970.
    • Petzold A, Keir G, Warren J, Fox N, Rossor MN (2007). A systematic review and meta-analysis of CSF neurofilament proteins levels as biomarkers in dementia.. Neurodegenerative Diseases, 4(2-3), 185 - 194. doi:10.1159/000101843
    • Ridha BH, Barnes J, van de Pol LA, Schott JM, Boyes RG, Siddique MM, Rossor MN, Scheltens P, Fox NC (2007). Application of automated medial temporal lobe atrophy scale to Alzheimer disease. Archives of Neurology, 64(6), 849 - 854. doi:10.1001/archneur.64.6.849
    • Chen KW, Reiman EM, Alexander GE, Caselli RJ, Gerkin R, Bandy D, Domb A, Osborne D, Fox N, Crum WR, Saunders AM, Hardy J (2007). Correlations between apolipoprotein E epsilon 4 gene dose and whole brain atrophy rates.
    • Feldman HH, Ferris S, Winblad B, Sfikas N, Mancione L, He YS, Tekin S, Burns A, Cummings J, del Ser T, Inzitari D, Orgogozo JM, Sauer H, Scheltens P, Scarpini E, Herrmann N, Farlow M, Potkin S, Charles HC, Fox NC, Lane R (2007). Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study. LANCET NEUROL, 6(6), 501 - 512. doi:10.1016/S1474-4422(07)70109-6
    • Barnes J, Foster J, Fox NC (2007). Structural magnetic resonance imaging-derived biomarkers for Alzheimer's disease. Biomarkers in Medicine, 1(1), 79 - 92. doi:10.2217/17520363.1.1.79
    • Barnes J, Lewis EB, Scahill RI, Bartlett JW, Frost C, Schott JM, Rossor MN, Fox NC (2007). Automated measurement of hippocampal atrophy using fluid-registered serial MRI in AD and controls. Journal of Computer Assisted Tomography, 31(4), 581 - 587.
    • Feldman HH, Ferris S, Winblad B, Sfikas N, Mancione L, He Y, Tekin S, Burns A, Cummings J, Del Ser T, Inzitari D, Orgogozo JM, Sauer H, Scheltens P, Scarpini E, Herrmann N, Farlow M, Potkin S, Charles HC, Fox NC, Lane R (2007). Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study. The Lancet Neurology, 6(6), 501 - 512. doi:10.1016/S1474-4422(07)70109-6
    • Smith SM, Rao A, De Stefano N, Jenkinson M, Schott JM, Matthews PM, Fox NC (2007). Longitudinal and cross-sectional analysis of atrophy in Alzheimer's disease: Cross-validation of BSI, SIENA and SIENAX. NeuroImage, 36(4), 1200 - 1206. doi:10.1016/j.neuroimage.2007.04.035
    • van de Pol LA, Korf ES, van der Flier WM, Brashear HR, Fox NC, Barkhof F, Scheltens P (2007). Magnetic resonance imaging predictors of cognition in mild cognitive impairment. Archives of Neurology, 64(7), 1023 - 1028. doi:10.1001/archneur.64.7.1023
    • Rohrer JD, Warren JD, Omar R, Barnes J, Mead S, Beck J, Collinge J, Stevens JM, Warrington EK, Rossor MN, Fox NC (2007). Longitudinal clinical, radiological and neuropsychological profile of an at-risk family member from a kindred with progranulin-associated frontotemporal lobar degeneration.
    • Ridha BH, Tozer DJ, Symms MR, Stockton KC, Lewis EB, Siddique MM, MacManus DG, Rossor MN, Fox NC, Tofts PS (2007). Quantitative magnetization transfer imaging in Alzheimer disease. Radiology, 244(3), 832 - 837.
    • Omar R, Henley SM, Hailstone JC, Sauter D, Scott SK, Fox NC, Rossor MN, Warren JD (2007). Recognition of emotions in faces, voices and music in frontotemporal lobar degeneration.
    • Anderson VM, Fisniku L, Fox NC, Miller D (2007). A comparison of atrophy rates in multiple sclerosis measured by SIENA from 2D and 3D MR acquisitions.
    • Anderson VM, Altmann DR, Fisniku L, Fox NC, Miller DH (2007). Effects of an MRI scanner upgrade on longitudinal measures of brain atrophy and application of a statistical correction method.
    • Barnes J, Boyes RG, Lewis EB, Schott JM, Frost C, Scahill RI, Fox NC (2007). Automatic calculation of hippocampal atrophy rates using a hippocampal template and boundary shift integral.. Neurobiology of Aging, 28(11), 1657 - 1663. doi:10.1016/j.neurobiolaging.2006.07.008
    • Anderson VM, Bartlett JW, Fox NC, Fisniku L, Miller DH (2007). Detecting treatment effects on brain atrophy in relapsing remitting multiple sclerosis: Sample size estimates. Journal of Neurology, 254(11), 1588 - 1594. doi:10.1007/s00415-007-0599-3
    • Scahill RI, Fox NC (2007). Longitudinal imaging in dementia. British Journal of Radiology, 80(Spec.No.2), S92 - S98. doi:10.1259/bjr/78981552

    2006

    • Godbolt AK, Waldman AD, MacManus DG, Schott JM, Frost C, Cipolotti L, Fox NC, Rossor MN (2006). MRS shows abnormalities before symptoms in familial Alzheimer disease. Neurology, 66(5), 718 - 722.
    • Garrard P, Schott JM, MacManus DG, Hodges JR, Fox NC, Waldman AD (2006). Posterior cingulate neurometabolite profiles and clinical phenotype in frontotemporal dementia.. Cogn Behav Neurol, 19(4), 185 - 189. doi:10.1097/01.wnn.0000213915.72395.77
    • Schott JM, Kennedy J, Fox NC (2006). New developments in mild cognitive impairment and Alzheimer's disease. Current Opinion in Neurology, 19(6), 552 - 558.
    • Archer HA, Macfarlane F, Price S, Moore EK, Pepple T, Cutler D, Frost C, Fox NC, Rossor MN (2006). Do symptoms of memory impairment correspond to cognitive impairment: a cross sectional study of a clinical cohort. International Journal of Geriatric Psychiatry, 21(12), 1206 - 1212. doi:10.1002/gps.1644
    • Jones BF, Barnes J, Uylings HBM, Fox NC, Frost C, Witter MP, Scheltens P (2006). Differential regional atrophy of the cingulate gyrus in Alzheimer disease: a volumetric MRI study. Cerebral Cortex, 16(12), 1701 - 1708. doi:10.1093/cercor/bhj105
    • Camara O, Schweiger M, Scahill RI, Crum WR, Sneller BI, Schnabel JA, Ridgway GR, Cash DM, Hill DLG, Fox NC (2006). Phenomenological model of diffuse global and regional atrophy using finite-element methods. IEEE Transactions on Medical Imaging, 25(11), 1417 - 1430. doi:10.1109/TMI.2006.880588
    • Ridha BH, Barnes J, Bartlett JW, Godbolt A, Pepple T, Rossor MN, Fox NC (2006). Tracking atrophy progression in familial Alzheimer's disease: a serial MRI study. The Lancet Neurology, 5(10), 828 - 834.
    • Barnes J, Whitwell JL, Frost C, Josephs KA, Rossor M, Fox NC (2006). Measurements of the amygdala and hippocampus in pathologically confirmed Alzheimer disease and frontotemporal lobar degeneration. Archives of Neurology, 63(10), 1434 - 1439.
    • Anderson VM, Bartlett JW, Fisniku L, Davies GR, Rashid W, Fox NC, Miller DH (2006). Sample size estimates based on hierarchical regression models of atrophy rates in relapsing-remitting multiple sclerosis.
    • Fox NC (2006). Neuroimaging in Alzheimer's disease.
    • Schott JM, Frost C, Whitwell JL, MacManus DG, Boyes RG, Rossor MN, Fox NC (2006). Combining short interval MRI in Alzheimer's disease : Implications for therapeutic trials. Journal of Neurology, 253(9), 1147 - 1153.
    • Furby J, Hayton T, Smith KJ, Altmann D, Brenner R, Chataway J, Fox NC, Hughes RAC, Miller DH, Kapoor R (2006). A randomised controlled trial of neuroprotection with lamotrigine in secondary progressive multiple sclerosis.
    • van der Flier WM, Schoonenboom SN, Pijnenburg YA, Fox NC, Scheltens P (2006). The effect of APOE genotype on clinical phenotype in Alzheimer disease. Neurology, 67(3), 526 - 527. doi:10.1212/01.wnl.0000228222.17111.2a
    • Henley SM, Frost C, MacManus DG, Warner TT, Fox NC, Tabrizi SJ (2006). Increased rate of whole-brain atrophy over 6 months in early Huntington disease. Neurology, 67(4), 694 - 696. doi:10.1212/01.wnl.0000230149.36635.c8
    • Boyes RG, Rueckert D, Aljabar P, Whitwell J, Schott JM, Hill DL, Fox NC (2006). Cerebral atrophy measurements using Jacobian integration: Comparison with the boundary shift integral. NeuroImage, 32(1), 159 - 169.
    • Paviour DC, Price SL, Jahanshahi M, Lees AJ, Fox NC (2006). Regional brain volumes distinguish PSP, MSA-P, and PD: MRI-based clinico-radiological correlations. Movement Disorders, 21(7), 989 - 996. doi:10.1002/mds.20877
    • Archer HA, Edison P, Brooks DJ, Barnes J, Frost C, Yeatman T, Fox NC, Rossor MN (2006). Amyloid load and cerebral atrophy in Alzheimer's disease: an 11C-PIB positron emission tomography study. Annals of Neurology, 60(1), 145 - 147. doi:10.1002/ana.20889
    • Leow AD, Klunder AD, Jack CR, Toga AW, Dale AM, Bernstein MA, Britson PJ, Gunter JL, Ward CP, Whitwell JL, Borowski BJ, Fleisher AS, Fox NC, Harvey D, Kornak J, Schuff N, Studholme C, Alexander GE, Weiner MW, Thompson PM (2006). Longitudinal stability of MRI for mapping brain change using tensor-based morphometry. NeuroImage, 31(2), 627 - 640. doi:10.1016/j.neuroimage.2005.12.013
    • Anderson VM, Fox NC, Fisniku L, Davies GR, Rashid W, Miller DH (2006). Sample size estimations to detect treatment effects in relapsing-remitting multiple sclerosis based on brain atrophy measurements from serial MRI.
    • Anderson VM, Fox NC, Miller DH (2006). Magnetic resonance imaging measures of brain atrophy in multiple sclerosis. Journal of Magnetic Resonance Imaging, 23(5), 605 - 618.
    • Edison P, Archer H, Hinz R, Fox N, Brooks DJ (2006). Relationship between the distribution of microglial activation, amyloid plaque load and cerebral glucose metabolism in Alzheimer's disease (AD): An 11C-PK11195, 18F-FDG and 11C-PIB PET study..
    • Paviour DC, Price SL, Jahanshahi M, Lees AJ, Fox NC (2006). Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy. Brain, 129(4), 1040 - 1049. doi:10.1093/brain/awl021
    • Fox N (2006). Immunotherapy of AD: MR imaging of changes in brain morphology.
    • Garrard P, Schott JM, MacManus DG, Hodges JR, Fox NC, Waldman AD (2006). Posterior cingulate neurometabolite profiles and clinical phenotype in frontotemporal dementia. Cognitive and Behavioral Neurology, 19(4), pp.185 - 189.
    • Schott JM, Ridha BH, Crutch SJ, Healy DG, Uphill JB, Warrington EK, Rossor MN, Fox NC (2006). Apolipoprotein E genotype modifies the phenotype of Alzheimer disease. Archives of Neurology, 63(1), 155 - 156.
    • Sneller B, Garde E, Atkinson D, Batchelor P, Fox NC, Hill DLG (2006). FLOW ARTIFACTS IN MR IMAGING FOR ALZHEIMER'S DETECTION AND PROGRESSION.
    • Sneller B, Garde E, Atkinson D, Batchelor P, Fox NC, Hill DLG (2006). FLOW ARTIFACTS IN MR IMAGING FOR ALZHEIMER'S DETECTION AND PROGRESSION.
    • Archer HA, Edison P, Fox NC, Barnes J, Frost C, Yeatman T, Brooks DJ, Rossor MN (2006). Relationship between amyloid deposition and atrophy rates in Alzheimer's disease using C-11-PIB radiotracer.
    • Camara-Rey O, Sneller BI, Ridgway GR, Garde E, Fox NC, Hill DL (2006). Simulation of acquisition artefacts in MR scans: effects on automatic measures of brain atrophy..
    • Camara-Rey O, Schweiger M, Scahill RI, Crum WR, Schnabell JA, Hill DL, Fox NC (2006). Simulation of local and global atrophy in Alzheimer's disease studies.. Med Image Comput Comput Assist Interv, 9(Pt 2), 937 - 945.
    • Godbolt AK, Beck JA, Collinge JC, Cipolotti L, Fox NC, Rossor MN (2006). A second family with familial AD and the V717L APP mutation has a later age at onset. Neurology, 66(4), 611 - 612.

    2005

    • Jager HR, Waldman AD, Benton C, Fox N, Rees J (2005). Differential chemosensitivity of tumor components in a malignant oligodendroglioma: Assessment with diffusion- weighted, perfusion-weighted, and serial volumetric MR imaging. American Journal of Neuroradiology, 26(2), 274 - 278.
    • Archer HA, Schott JM, Barnes J, Fox NC, Holton JL, Revesz T, Cipolotti L, Rossor MN (2005). Knight's move thinking? Mild cognitive impairment in a chess player. Neurocase, 11(1), 26 - 31.
    • Barnes J, Scahill RI, Schott JM, Frost C, Rossor MN, Fox NC (2005). Does Alzheimer's disease affect hippocampal asymmetry? Evidence from a cross-sectional and longitudinal volumetric MRI study. Dementia and Geriatric Cognitive Disorders, 19(5-6), 338 - 344.
    • Schweiger M, Camara-Rey O, Crum WR, Lewis E, Schnabel J, Arridge SR, Hill DLG, Fox N (2005). An inverse problem approach to the estimation of volume change.
    • Ridha BH, Schott JM, Crutch SJ, Healy DG, Uphill JB, Warrington EW, Rossor MN, Fox NC (2005). Apoliprotein E genotype modifies the phenotype of Alzheimer's disease.
    • Henley SMD, Warrington EK, Frost C, MacManus DG, Warner TT, Fox NC, Tabrizi SJ (2005). Mri and cognitive changes detectable over 6 and 12 months in early Huntington's disease.
    • Likeman M, Anderson VM, Stevens JM, Waldman AD, Godbolt AK, Frost C, Rossor MN, Fox NC (2005). Visual assessment of atrophy on magnetic resonance imaging in the diagnosis of pathologically confirmed young-onset dementias. Archives of Neurology, 62(9), 1410 - 1415.
    • Anderson VM, Fernando KTM, Swanton JK, Frost C, Fox NC, Miller DH (2005). MRI measures of ventricular enlargement in subjects presenting with clinically isolated syndromes may aid prognosis of multiple sclerosis development.
    • Whitwell JL, Josephs KA, Rossor MN, Stevens JM, Revesz T, Holton JL, Al Sarraj S, Godbolt AK, Fox NC, Warren JD (2005). Magnetic resonance imaging signatures of tissue pathology in frontotemporal dementia. Archives of Neurology, 62(9), 1402 - 1408.
    • Anderson VM, Fernando KTM, Davies GR, Rashid W, Fox NC, Miller DH (2005). Comparison of segmentation- and registration-based longitudinal brain atrophy measurements in subjects presenting with clinically isolated syndromes and early relapsing-remitting multiple sclerosis.
    • Schott JM, Warren JD, Fox NC, Thom M, Revesz T, Scaravilli F, Holton J, Thomas DGT, Plant GT, Rudge P, Rossor MN (2005). Brain biopsy in dementia: A review of 90 consecutive cases from Queen Square.
    • Whitwell JL, Sampson EL, Watt HC, Harvey RJ, Rossor MN, Fox NC (2005). A volumetric magnetic resonance imaging study of the amygdala in frontotemporal lobar degeneration and Alzheimer's disease. Dementia and Geriatric Cognitive Disorders, 20(4), 238 - 244. doi:10.1159/000087343
    • Paviour DC, Winterburn D, Simmonds S, Burgess G, Wilkinson L, Fox NC, Lees AJ, Jahanshahi M (2005). Can the frontal assessment battery (FAB) differentiate bradykinetic rigid syndromes? Relation of the FAB to formal neuropsychological testing. Neurocase, 11(4), 274 - 282.
    • Godbolt AK, Josephs KA, Revesz T, Warrington EK, Lantos P, King A, Fox NC, Al Sarraj S, Holton J, Cipolotti L, Khan MN, Rossor MN (2005). Sporadic and familial dementia with ubiquitin-positive tau-negative inclusions: clinical features of one histopathological abnormality underlying frontotemporal lobar degeneration. Archives of Neurology, 62(7), 1097 - 1101.
    • Rees J, Watt H, Benton C, Fox N, Tofts P, Jager H, Waldman A (2005). Measuring growth rates of low-grade gliomas may predict early malignant transformation.
    • Schott JM, Price SL, Frost C, Whitwell JL, Rossor MN, Fox NC (2005). Measuring atrophy in Alzheimer disease: a serial MRI study over 6 and 12 months. Neurology, 65(1), 119 - 124.
    • Fox N (2005). MRI in dementia.
    • Fox NC, Black RS, Gilman S, Rossor MN, Griffith SG, Jenkins L, Koller M (2005). Effects of A beta immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease. Neurology, 64(9), 1563 - 1572. doi:10.1212/01.WNL.0000159743.08996.99
    • Gilman S, Koller M, Black RS, Jenkins L, Griffith SG, Fox NC, Eisner L, Kirby L, Rovira MB, Forette F, Orgogozo JM (2005). Clinical effects of A beta immunization (AN1792) in patients with AD in an interrupted trial. Neurology, 64(9), 1553 - 1562.
    • Warren JD, Schott JM, Fox NC, Thom M, Revesz T, Holton JL, Scaravilli F, Thomas DG, Plant GT, Rudge P, Rossor MN (2005). Brain biopsy in dementia. Brain, 128(9), 2016 - 2025. doi:10.1093/brain/awh543
    • Godbolt AK, Cipolotti L, Watt H, Janssen JC, Fox NC, Rossor MN (2005). Survival in Alzheimer disease - In reply. Archives of Neurology, 62(4), 689 - 690.
    • Paviour DC, Price SL, Stevens JM, Lees AJ, Fox NC (2005). Quantitative MRI measurement of superior cerebellar peduncle in progressive supranuclear palsy.. Neurology, 64(4), 675 - 679.
    • Janssen JC, Schott JM, Cipolotti L, Fox NC, Scahill RI, Josephs KA, Stevens JM, Rossor MN (2005). Mapping the onset and progression of atrophy in familial frontotemporal lobar degeneration. Journal of Neurology, Neurosurgery and Psychiatry, 76(2), 162 - 168.
    • Godbolt AK, Cipolotti L, Anderson VM, Archer H, Janssen JC, Price S, Rossor MN, Fox NC (2005). A decade of pre-diagnostic assessment in a case of familial Alzheimer's disease: tracking progression from asymptomatic to MCI and dementia. Neurocase, 11(1), 56 - 64.

    2004

    • Chen K, Reiman EM, Alexander GE, Caselli R, Domb A, Bandy D, Crum W, Rossor M, Fox N (2004). Whole brain atrophy rates in cognitively normal persons at genetic risk for Alzheimer's disease.
    • Paling SM, Williams ED, Barber R, Burton EJ, Crum WR, Fox NC, O'Brien JT (2004). The application of serial MRI analysis techniques to the study of cerebral atrophy in late-onset dementia. Medical Image Analysis, 8(1), 69 - 79. doi:10.1016/j.media.2003.07.004
    • Fox N, Paviour D (2004). Volumetric MRI studies in progressive supranuclear palsy.
    • Fox N, Growdon JH (2004). Biomarkers and surrogates. Neurorx, 1(2), 181 - 181.
    • Fox N, Schott J, Barnes J, Price S, Anderson V, Whitwell J, Rossor M (2004). MRI to measure progression to AD and in AD.
    • Chen KW, Reiman EM, Alexander GE, Bandy D, Renaut R, Crum WR, Fox NC, Rossor MN (2004). An automated algorithm for the computation of brain volume change from sequential MRIs using an iterative principal component analysis and its evaluation for the assessment of whole-brain atrophy rates in patients with probable Alzheimer's disease. NeuroImage, 22(1), 134 - 143.
    • Schott JM, Janssen JC, Cipolotti L, Fox NC, Scahill RI, Josephs KA, Stevens JM, Rossor MN (2004). Presymptomatic focal atrophy precedes speech production impairment in familial frontotemporal lobar degeneration.
    • O'Brien JT, Burton E, McKeith I, Fox N (2004). Alzheimer's disease and dementia with lewy bodies show different regional patterns of evolving atrophy using fluid registration of serial MRI scans.
    • Henley SM, Warrington EK, Warner TT, Stevens JM, Ashburner J, Rossor MN, Fox NC, Tabrizi SJ (2004). Correlation between patterns of atrophy and psychomotor task performance in early Huntington's disease.
    • Fox NC, Black RS, Gilman S, Rossor MN, Griffith SG, Jenkins L, Koller M (2004). Effects of A-beta immunotherapy (AN1792) on MRI measures of brain, ventricle and hippocampal volumes in Alzheimer's disease.
    • Ridha BH, Symms MR, Lewis EB, MacManus DG, Boulby PA, Barker GJ, Tofts PS, Rossor MN, Fox NC (2004). Magnetization transfer imaging of the hippocampal formation: Application to Alzheimer's disease.
    • Barnes J, Godbolt AK, Frost C, Boyes RG, Jones BF, Rossor MN, Fox NC (2004). Measurement of rates of atrophy in the cingulate gyrus and its subdivisions in a group of patients with confirmed Alzheimer's disease (AD) and frontotemporal lobar degeneration (FTLD).
    • Gilman S, Koller M, Black RS, Jenkins L, Griffith SG, Fox NC, Eisner L, Kirby L, Boada M, Forette F, Orgogozo JM (2004). Neuropsychological, CSF, and neuropathological effects of A-beta immunotherapy (AN1792) of Alzheimer's disease in an interrupted trial.
    • Whitwell JL, Godbolt AK, Josephs KA, Stevens JM, Rossor MN, Fox NC (2004). Patterns of atrophy on MRI in histologically-proven sporadic Alzheimer's disease and genetically-proven familial Alzheimer's disease.
    • Schott JM, Frost C, Crutch SJ, Boyes RG, Whitwell JL, Scahill RI, Rossor MN, Warrington EK, Fox NC (2004). Predictors and correlates of inter-individual variation in MRI derived atrophy rates in Alzheimer's disease.
    • Ridha BH, Anderson VM, Barnes J, Boyes RG, Price SL, Rossor MN, Whitwell JL, Black RS, Griffith SG, Jenkins L, Koller M, Fox NC (2004). Rates of hippocampal and brain atrophy, and ventricular enlargement, in Alzheimer's disease: A comparison of markers of progression.
    • Fox NC, Schott JM, Frost C, Rossor MN (2004). Serial magnetic resonance imaging as an outcome measure in dementia.
    • Whitwell JL, Josephs KA, Godbolt AK, Stevens JM, Fox NC, Rossor MN (2004). The relationship between specific histopathology and patterns of atrophy on MRI in frontotemporal lobar degeneration.
    • Lewis EB, Fox NC (2004). Correction of differential intensity inhomogeneity in longitudinal MR images. NeuroImage, 23(1), 75 - 83.
    • Whitwell JL, Schott JM, Lewis EB, MacManus DG, Fox NC (2004). Using nine degrees-of-freedom registration to correct for changes in voxel size in serial MRI studies. Magnetic Resonance Imaging, 22(7), 993 - 999.
    • Barnes J, Scahill RI, Boyes RG, Frost C, Lewis EB, Rossor CL, Rossor MN, Fox NC (2004). Differentiating AD from aging using semiautomated measurement of hippocampal atrophy rates. NeuroImage, 23(2), 574 - 581.
    • Karas GB, Scheltens P, Rombouts SARB, Visser PJ, Van Schijndel R, Fox NC, Barkhof F (2004). Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease. NeuroImage, 23(2), 708 - 716. doi:10.1016/j.neuroimage.2004.07.006
    • Price S, Paviour D, Scahill R, Stevens J, Rossor M, Lees A, Fox N (2004). Voxel-based morphometry detects patterns of atrophy that help differentiate progressive supranuclear palsy and Parkinson's disease.. Neuroimage, 23(2), 663 - 669.
    • Godbolt A, Beck J, Collinge J, Garrard P, Warren JD, Fox NC, Rossor MN (2004). A presenilin 1 R2781 mutation presenting with language impairment. Neurology, 63(9), 1702 - 1704.
    • Frost C, Kenward MG, Fox NC (2004). The analysis of repeated 'direct' measures of change illustrated with an application in longitudinal imaging. Statistics in Medicine, 23(21), 3275 - 3286. doi:10.1002/sim.1909
    • Godbolt AK, Cipolotti L, Watt H, Fox NC, Janssen JC, Rossor MN (2004). The natural history of Alzheimer disease - A longitudinal presymptomatic and symptomatic study of a familial cohort. Archives of Neurology, 61(11), 1743 - 1748.
    • Whitwell JL, Warren JD, Josephs KA, Godbolt AK, Revesz T, Fox NC, Rossor MN (2004). Voxel-based morphometry in tau-positive and tau-negative frontotemporal lobar degenerations. Neurodegenerative Diseases, 1(4-5), 225 - 230. doi:10.1159/000080990
    • Paviour DC, Schott JM, Stevens JM, Revesz T, Holton JL, Rossor MN, Lees AJ, Fox NC (2004). Pathological substrate for regional distribution of increased atrophy rates in progressive supranuclear palsy. Journal of Neurology, Neurosurgery and Psychiatry, 75(12), 1772 - 1775.
    • Cena B, Fox N, Rees J (2004). Fluid deformation of serial structural MRI for low-grade glioma growth analysis. Lecture Notes In Computer Science, 3217, 1055 - 1056.
    • Fox NCI, Schott JM (2004). Imaging cerebral atrophy: normal ageing to Alzheimer's disease. The Lancet, 363(9406), 392 - 394. doi:10.1016/S0140-6736(04)15441-X
    • Boyes RG, Schott JM, Frost C, Fox NC (2004). Increasing accuracy of atrophy measures from serial MR scans using parameter analysis of the boundary shift integral. Lecture Notes In Computer Science, 3217, 1036 - 1037.
    • Whitwell JL, Anderson VM, Scahill RI, Rossor MN, Fox NC (2004). Longitudinal patterns of regional change on volumetric MRI in frontotemporal lobar degeneration. Dementia and Geriatric Cognitive Disorders, 17(4), 307 - 310.
    • Fox NC, Schott JM, Scahill RI (2004). Measuring progression in Alzheimer's disease using serial MRI: 4D MRI. In Hyman B, Demonet JF, Christen Y (Ed.), The Living Brain and Alzheimer's Disease (pp. 61 - 74). : Springer-Verlag.
    • Chen K, Reiman EM, Alexander GE, Crum WR, Fox NC, Rossor MN (2004). Automated method using iterative principal component analysis for detecting brain atrophy rates from sequential MRI in persons with Alzheimer's disease.
    • Schott JM, Fox NC, Frost C, Scahill RI, Chan D, Janssen JC, Jenkins R, Rossor MN (2004). Familial Alzheimer's disease: How early does medial temporal lobe atrophy occur?.
    • Scahill RI, Schott JM, Stevens JM, Janssen JC, Rossor MN, Fox NC (2004). Fluid registration of serial MRI: Identifying regional changes in Alzheimer's disease.

    2003

    • Josephs KA, Holton JL, Rossor MN, Braendgaard H, Ozawa T, Fox NC, Petersen RC, Pearl GS, Ganguly M, Rosa P, Laursen H, Parisi JE, Waldemar G, Quinn NP, Dickson DW, Revesz T (2003). Neurofilament inclusion body disease: a new proteinopathy?. Brain, 126(10), 2291 - 2303. doi:10.1093/brain/awg231
    • Frisoni GB, Scheltens P, Galluzzi S, Nobili FM, Fox NC, Robert PH, Soininen H, Wahlund LO, Waldemar G, Salmon E (2003). Neuroimaging tools to rate regional atrophy, subcortical cerebrovascular disease, and regional cerebral blood flow and metabolism: consensus paper of the EADC. Journal of Neurology, Neurosurgery and Psychiatry, 74(10), 1371 - 1381.
    • Walters RJL, Fox NC, Crum WR, Stevens JM, Rossor MN, Thomas DJ (2003). Cerebral atrophy variation over short time intervals in transient ischaemic attack (TIA) patients.
    • Rees JH, Benton C, Fox N, Waldman A, Moore EA, Jager R, Stevens J, Tofts P (2003). Volumetric registration of low grade gliomas: A quantitative approach to measuring tumour.
    • Chan D, Anderson V, Sampson EL, Scahill RI, Whitwell JL, Stevens JM, Fox NC, Rossor MN (2003). The clinical and behavioural correlates of right temporal lobe atrophy.
    • Schott JM, Paviour DC, Fox NC, Stevens JM, Lees AJ, Rossor MN (2003). Picturing the atrophy patterns of progressive supranuclear palsy and multiple system atrophy in vivo using fluid registered MRI.
    • Janssen JC, Chan DC, Jenkins R, Whitwell J, Watt H, Frost C, Fox NC, Rossor MN (2003). Do rates of cerebral atrophy in Alzheimer's disease accelerate?.
    • Schott JM, Crutch SJ, Fox NC, Warrington EK (2003). Development of selective verbal memory impairment secondary to a left thalamic infarct: a longitudinal case study. Journal of Neurology, Neurosurgery and Psychiatry, 74(2), 255 - 257.
    • Ashburner J, Csernansky JG, Davatzikos C, Fox NC, Frisoni GB, Thompson PM (2003). Computer-assisted imaging to assess brain structure in healthy and diseased brains. The Lancet Neurology, 2(2), 79 - 88.
    • Schott JM, Fox NC, Frost C, Scahill RI, Janssen JC, Chan D, Jenkins R, Rossor MN (2003). Assessing the onset of structural change in familial Alzheimer's disease. Annals of Neurology, 53(2), 181 - 188. doi:10.1002/ana.10424
    • Pijnenburg YAL, Sampson EL, Harvey RJ, Fox NC, Rossor MN (2003). Vulnerability to neuroleptic side effects in frontotemporal lobar degeneration. International Journal of Geriatric Psychiatry, 18(1), 67 - 72.
    • Walters RJL, Fox NC, Schott JM, Crum WR, Stevens JM, Rossor MN, Thomas DJ (2003). Transient ischaemic attacks are associated with increased rates of global cerebral atrophy. Journal of Neurology, Neurosurgery and Psychiatry, 74(2), 213 - 216.
    • Warren JD, Warren JE, Fox NC, Warrington EK (2003). Nothing to say, something to sing: primary progressive dynamic aphasia. Neurocase, 9(2), 140 - 155.
    • Janssen JC, Beck JA, Campbell TA, Dickinson A, Fox NC, Harvey RJ, Houlden H, Rossor MN, Collinge J (2003). Early onset familial Alzheimer's disease: Mutation frequency in 31 families. Neurology, 60(2), 235 - 239.
    • Schott JM, Simon JE, Fox NC, King AP, Khan MN, Cipolotti L, Paviour DC, Stevens JM, Rossor MN (2003). Delineating the sites and progression of in vivo atrophy in multiple system atrophy using fluid-registered MRI. Movement Disorders, 18(8), 955 - 958.
    • Petzold A, Jenkins R, Watt HC, Green AJE, Thompson EJ, Keir G, Fox NC, Rossor MN (2003). Cerebrospinal fluid S100B correlates with brain atrophy in Alzheimer's disease. Neuroscience Letters, 336(3), 167 - 170.
    • Scahill RI, Frost C, Jenkins R, Whitwell JL, Rossor MN, Fox NC (2003). A longitudinal study of brain volume changes in normal aging using serial registered magnetic resonance imaging. Archives of Neurology, 60(7), 989 - 994.
    • Chan D, Janssen JC, Whitwell JL, Watt HC, Jenkins R, Frost C, Rossor MN, Fox NC (2003). Change in rates of cerebral atrophy over time in early-onset Alzheimer's disease: longitudinal MRI study. The Lancet, 362(9390), 1121 - 1122. doi:10.1016/S0140-6736(03)14469-8

    2002

    • Dalton CM, Brex PA, Jenkins R, Fox NC, Miszkiel KA, Crum WR, O'Riordan JI, Plant GT, Thompson AJ, Miller DH (2002). Progressive ventricular enlargement in patients with clinically isolated syndromes is associated with the early development of multiple sclerosis. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 73(2), 141 - 147.
    • Schott JM, Fox NC, Rossor MN (2002). Genetics of the dementias.. J Neurol Neurosurg Psychiatry, 73 Suppl 2, II27 - II31.
    • Fox N (2002). How can we assess disease-modification in AD? How can we design prevention studies?.
    • Good CD, Scahill RI, Fox NC, Ashburner J, Friston KJ, Chan D, Crum WR, Rossor MN, Frackowiak RSJ (2002). Automatic differentiation of anatomical patterns in the human brain: Validation with studies of degenerative dementias. NeuroImage, 17(1), 29 - 46. doi:10.1006/nimg.2002.1202
    • Janssen JC, Beck JA, Campbell TA, Dickinson A, Fox NC, Harvey RJ, Houlden H, Rosser MN, Collinge J (2002). Early onset familial alzheimer's disease: Mutation frequency in 31 families. J NEUROL NEUROSUR PS, 73(2), 219 - 219.
    • Chen KW, Reiman E, Domb A, Bandy D, Alexander G, Caselli R, Crum W, Rossor M, Fox N (2002). Whole brain atrophy rates in cognitively normal persons at genetic risk for Alzheimer's disease. NEUROBIOL AGING, 23(1), S349 - S349.
    • Fox NC (2002). Using MRI to measure progression in Alzheimer's disease. NEUROBIOL AGING, 23(1), S562 - S562.
    • Janssen JC, Scahill RI, Schott JM, Whitwell J, Warrington E, Rossor MN, Fox NC, Stevens JM, Cipolotti L (2002). In vivo mapping of the onset and progression of neurodegeneration in frontotemporal lobar degeneration. NEUROBIOL AGING, 23(1), S479 - S479.
    • Scahill RI, Schott JM, Stevens JM, Rossor MN, Fox NC (2002). Mapping the evolution of regional atrophy in Alzheimer's disease: unbiased analysis of fluid-registered serial MRI. Proceedings of the National Academy of Sciences of the United States of America, 99(7), 4703 - 4707. doi:10.1073/pnas.052587399
    • Scheltens P, Fox N, Barkhof F, Decarli C (2002). Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion. The Lancet Neurology, 1(1), 13 - 21.
    • O'Riordan S, McMonagle P, Janssen JC, Fox NC, Farrell M, Collinge J, Rossor MN, Hutchinson M (2002). Presenilin-1 mutation (E280G), spastic paraparesis, and cranial MRI whitematter abnormalities. Neurology, 59(7), 1108 - 1110.
    • Hogh P, Smith SJ, Scahill RI, Chan D, Harvey RJ, Fox NC, Rossor MN (2002). Epilepsy presenting as AD: Neuroimaging, electroclinical features, and response to treatment. Neurology, 58(2), 298 - 301.
    • Janssen JC, Warrington EK, Morris HR, Lantos P, Brown J, Revesz T, Wood N, Khan MN, Cipolotti L, Fox NC, Rossor MN (2002). Clinical features of frontotemporal dementia due to the intronic tau 10(+16) mutation. Neurology, 58(8), 1161 - 1168.

    2001

    • Crum WR, Scahill RI, Fox NC (2001). Automated hippocampal segmentation by regional fluid registration of serial MRI: Validation and application in Alzheimer's disease. NeuroImage, 13(5), 847 - 855. doi:10.1006/nimg.2001.0744
    • Fox NC, Jenkins R, Rossor M (2001). Premorbid brain volume and dementia - Reply. ARCH NEUROL-CHICAGO, 58(5), 832 - 833.
    • Fox NCI, Crum WR, Scahill RI, Stevens JM, Janssen JC, Rossor MN (2001). Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance images. The Lancet, 358(9277), 201 - 205. doi:10.1016/S0140-6736(01)05408-3
    • Chan D, Fox NC, Jenkins R, Scahill RI, Crum WR, Rossor MN (2001). Rates of global and regional cerebral atrophy in AD and frontotemporal dementia. Neurology, 57(10), 1756 - 1763.
    • Walters RJL, Fox NC, Crum WR, Taube D, Thomas DJ (2001). Haemodialysis and cerebral oedema. Nephron, 87(2), 143 - 147.
    • Janssen JC, Lantos PL, Fox NC, Harvey RJ, Beck J, Dickinson A, Campbell TA, Collinge J, Hanger DP, Cipolotti L, Stevens JM, Rossor MN (2001). Autopsy-confirmed familial early-onset Alzheimer disease caused by the L153V presenilin 1 mutation. Archives of Neurology, 58(6), 953 - 958.
    • O'Brien JT, Paling S, Barber R, Williams ED, Ballard C, McKeith IG, Gholkar A, Crum WR, Rossor MN, Fox NC (2001). Progressive brain atrophy on serial MRI in dementia with Lewy bodies, AD, and vascular dementia. Neurology, 56(10), 1386 - 1388.
    • Chan D, Fox N, Scahill R, Crum W, Whitwell J, Cipolotti L, Rossor MN (2001). Patterns of temporal lobe atrophy in semantic dementia and Alzheimer's disease. J NEUROL NEUROSUR PS, 70(2), 276 - 276.
    • Whitwell JL, Crum WR, Watt HC, Fox NC (2001). Normalization of cerebral volumes by use of intracranial volume: implications for longitudinal quantitative MR imaging. American Journal of Neuroradiology, 22(8), 1483 - 1489.
    • Rossor MN, Janssen JC, Fox NC, Harvey RJ, Stevens J, Warrington EK (2001). Lessons in familial Alzheimer's disease. In Tanaka C, McGreer PL, Ihara Y (Ed.), Neuroscientific basis of dementia (pp. 259 - 265). : Birkhauser.
    • Chan D, Fox NC, Scahill RI, Crum WR, Whitwell JL, Leschziner G, Rossor AM, Stevens JM, Cipolotti L, Rossor MN (2001). Patterns of temporal lobe atrophy in semantic dementia and Alzheimer's disease. Annals of Neurology, 49(4), 433 - 442. doi:10.1002/ana.92
    • Cipolotti L, Shallice T, Chan D, Fox N, Scahill R, Harrison G, Stevens J, Rudge P (2001). Long-term retrograde amnesia: the crucial role of the hippocampus. Neuropsychologia, 39(2), 151 - 172. doi:10.1016/S0028-3932(00)00103-2
    • Stevens JM, Fox NC (2001). Structural imaging. In Hodges JR (Ed.), Early-onset dementia: a multidisciplinary approach (pp. 124 - 141). : Oxford University Press.
    • Fox N, Scahill R, Hogh P, Rossor MN (2001). Alzheimer's disease and neuroimaging. In Dawbarn D, Allen SJ (Ed.), Neurobiology of Alzheimer's disease: molecular and cellular neurobiology (Molecular and Cellular Neurobiology Series) (pp. 312 - 337). : Oxford University Press.

    2000

    • Fox NC, Cousens S, Scahill R, Harvey RJ, Rossor MN (2000). Using serial registered brain magnetic resonance imaging to measure disease progression in Alzheimer disease: power calculations and estimates of sample size to detect treatment effects. Archives of Neurology, 57(3), 339 - 344.
    • Fox NC, Rossor MN (2000). Seeing what Alzheimer saw: with magnetic resonance microscopy. Nature Medicine, 6(1), 20 - 21.
    • Fox NC, Jenkins R, Leary SM, Stevenson VL, Losseff NA, Crum WR, Harvey RJ, Rossor MN, Miller DH, Thompson AJ (2000). Progressive cerebral atrophy in MS: a serial study using registered, volumetric MRI. Neurology, 54(4), 807 - 812.
    • Rossor MN, Fox NC (2000). Mere forgetfulness or early Alzheimer's disease?. Annals of Neurology, 47(4), 419 - 420.
    • Von Gunten A, Fox NC, Cipolotti L, Ron MA (2000). A volumetric study of hippocampus and amygdala in depressed patients with subjective memory problems. Journal of Neuropsychiatry and Clinical Neurosciences, 12(4), 493 - 498.
    • Janssen JC, Hall M, Fox NC, Harvey RJ, Beck J, Dickinson A, Campbell T, Collinge J, Lantos PL, Cipolotti L, Stevens JM, Rossor MN (2000). Alzheimer's disease due to an intronic presenilin-1 (PSEN1 intron 4) mutation: a clinicopathological study. Brain, 123, 894 - 907.
    • Wang T, Sharma SD, Fox NC, Rossor MN, Brown MJ, Sharma P (2000). Description of a simple test for CADASIL disease and determination of mutation frequencies in sporadic ischaemic stroke and dementia patients. Journal of Neurology, Neurosurgery and Psychiatry, 69, 652 - 654.
    • Jenkins R, Fox NC, Rossor AM, Harvey RJ, Rossor MN (2000). Intracranial volume and Alzheimer disease: evidence against the cerebral reserve hypothesis. Archives of Neurology, 57(2), 220 - 224.
    • Brex PA, Jenkins R, Fox NC, Crum WR, O'Riordan JI, Plant GT, Miller DH (2000). Detection of ventricular enlargement in patients at the earliest clinical stage of MS. Neurology, 54(8), 1689 - 1691.

    1999

    • Fox NC, Scahill RI, Crum WR, Rossor MN (1999). Correlation between rates of brain atrophy and cognitive decline in AD. Neurology, 52, 1687 - 1689.
    • Fox NC (1999). Case 48. In Wills AJ, Marsden CD (Ed.), Fifty neurological cases from the National Hospital (pp. 155 - 156). : Martin Dunitz.
    • Harvey RJ, Fox NC, Rossor MN (1999). Dementia.
    • Fox NC, Rossor MN (1999). Diagnosis of early Alzheimer's disease. Revue Neurologique, 155 (S(Suppl), 33 - 37.
    • Fox NC (1999). Magnetic resonance imaging in Alzheimer's disease: from diagnosis to measuring therapeutic effect. Alzheimers Reports, 2(1), 5 - 12.
    • Fox NC, Warrington EK, Rossor MN (1999). Serial magnetic resonance imaging of cerebral atrophy in preclinical Alzheimer's disease. The Lancet, 353, 2125 - .

    1998

    • Wilkinson ID, Fox NC, Freeborough PA, Miller RF (1998). Visualisation and quantification of HIV related brain atrophy using registered serial magnetic resonance imaging. SEX TRANSM INFECT, 74(1), 76 - 76.
    • Wilkinson ID, Fox NC, Freeborough PA, Miller RF (1998). Visualisation and quantification of HIV-related brain atrophy using registered serial MRI. Sexually Transmitted Infections, 74, 76 - 76.
    • Fox NC, Warrington EK, Seiffer AL, Agnew SK, Rossor MN (1998). Presymptomatic cognitive deficits in individuals at risk of familial Alzheimer's disease - a longitudinal prospective study. Brain, 121, 1631 - 1639.
    • Freeborough PA, Fox NC (1998). MR image texture analysis applied to the diagnosis and tracking of Alzheimer's disease. IEEE Transactions on Medical Imaging, 17, 475 - 479.
    • Fox NC (1998). Imaging atrophy in Alzheimer's disease. Alzheimer's Review, 8(1), 168 - 172.
    • Harvey RJ, Ellison D, Hardy J, Hutton M, Rogues P, Collinge J, Fox NC, Rossor MN (1998). Chromosome 14 familial Alzheimer's disease: the clinical and neuropathological characteristics of a family with a leucine->serine (L250S) substitution at codon 250 of the presenilin 1 gene. Journal of Neurology, Neurosurgery and Psychiatry, 64, 44 - 49.
    • Harvey RJ, Roques PK, Fox NC, Rossor MN (1998). CANDID-counselling and diagnosis in dementia: a national telemedicine service supporting the care of younger patients with dementia. International Journal of Geriatric Psychiatry, 13, 381 - 388.
    • Freeborough PA, Fox NC (1998). Modeling brain deformations in Alzheimer disease by fluid registration of serial 3D MR images. Journal of Computer Assisted Tomography, 22, 838 - 843.

    1997

    • Fox NC, Freeborough PA (1997). Brain atrophy progression measured from registered serial MRI: Validation and application to Alzheimer's disease. J MAGN RESON IMAGING, 7(6), 1069 - 1075.
    • Freeborough PA, Fox NC (1997). Measurement of global and regional cerebral volume changes by integrating boundary shifts between registered serial 3D MR scans.
    • Rossor MN, Fox NC, Freeborough PA, Roques PK (1997). Slowing the progression of Alzheimer disease: monitoring progression.. Alzheimer Dis Assoc Disord, 11 Suppl 5, S6 - S9.
    • Freeborough PA, Fox NC (1997). The boundary shift integral: An accurate and robust measure of cerebral volume changes from registered repeat MRI. Ieee Transactions On Medical Imaging, 16, 623 - 629.
    • Freeborough PA, Fox NC (1997). Measurement of brain volume changes in Alzheimer's disease from registered serial MR scans. Clinical MRI, 7, 23 - 26.
    • Freeborough PA, Fox NC, Kitney RI (1997). Interactive algorithms for the segmentation and quantitation of 3D MRI brain scans. Computer Methods And Programs In Biomedicine, 53, 15 - 25.
    • Harvey RJ, Summerfield JA, Fox NC, Warrington EK, Rossor MN (1997). Dementia associated with haemochromatosis: a report of two cases. European Journal of Neurology, 4, 318 - 322.
    • Fox NC, Kennedy AM, Harvey RJ, Lantos PL, Roques P, Collinge J, Hardy J, Hutton M, Stevens JM, Warrington EK, Rossor MN (1997). Clinicopathological features of familial Alzheimer's disease associated with the M139V mutation in the presenilin 1 gene - pedigree but not mutation specific age at onset provides evidence for a further genetic factor. Brain, 120, 491 - 501.
    • Fox NC, Freeborough PA, Mekkaoui KF, Stevens JM, Rossor MN (1997). Cerebral and cerebellar atrophy on serial magnetic resonance imaging in an initially symptom free subject at risk of familial prion disease. BMJ (Clinical Research Ed.), 315, 856 - 857.

    1996

    • Rossor MN, Fox NC, Freeborough PA, Harvey RJ (1996). Clinical features of sporadic and familial Alzheimer's disease.. Neurodegeneration, 5(4), 393 - 397.
    • Fox NC, Warrington EK, Freeborough PA, Hartikainen P, Kennedy AM, Stevens JM, Rossor MN (1996). Presymptomatic hippocampal atrophy in Alzheimer's disease. A longitudinal MRI study.. Brain, 119 ( Pt 6), 2001 - 2007.
    • Freeborough PA, Woods RP, Fox NC (1996). Accurate registration of serial 3D MR brain images and its application to visualizing change in neurodegenerative disorders. J COMPUT ASSIST TOMO, 20(6), 1012 - 1022.
    • Fox NC, Freeborough PA, Rossor MN (1996). Visualisation and quantification of rates of atrophy in Alzheimer's disease.. Lancet, 348(9020), 94 - 97.
    • Rossor MN, Fox NC, Beck J, Campbell TC, Collinge J (1996). Incomplete penetrance of familial Alzheimer's disease in a pedigree with a novel presenilin-1 gene mutation. LANCET, 347(9014), 1560 - 1560.
    • Harvey RJ, Roques P, Fox NC, Rossor MN (1996). Non-Alzheimer dementias in young patients.. Br J Psychiatry, 168(3), 384 - 385.
    • Fox NC, Warrington EK, Stevens JM, Rossor MN (1996). Atrophy of the hippocampal formation in early familial Alzheimer's disease. A longitudinal MRI study of at-risk members of a family with an amyloid precursor protein 717Val-Gly mutation.. Ann N Y Acad Sci, 777, 226 - 232.
    • Fox N, Harvey RJ, Rossor MN (1996). Protein folding, nucleation phenomena and delayed neurodegeneration in Alzheimer's disease.. Rev Neurosci, 7(1), 21 - 28.

    • Hobbs NZ, Henley SMD, Ridgway GR, Wild EJ, Barker RJ, Scahill RI, Barnes J, Fox NC, Tabrizi SJ (). The progression of regional atrophy in premanifest and early Huntington's disease: A longitudinal voxel-based morphometry study.. Journal of Neurology, Neurosurgery and Psychiatry, , - .
    • Ahmed R, Guerreiro R, Rohrer JD, Guven G, Rossor MN, Hardy J, Fox NC (). A novel A781V mutation in the CSF1R gene causes hereditary diffuse leucoencephalopathy with axonal spheroids. Journal of the Neurological Sciences, , - . doi:10.1016/j.jns.2013.06.007
    • Malone I, Leung KL, Clegg S, Barnes J, Whitwell JL, Ashburner J, Fox NC, Ridgway GR (). Accurate automatic estimation of total intracranial volume: a nuisance variable with less nuisance. Neuroimage, , - .